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ABSTRACT

PROMOTION OF COLON HEALTH BY STRAWBERRY AND CRANBERRY

FEBRUARY 2020

YANHUI HAN

B.S., SOUTHWEST UNIVERSITY, CHINA

Ph.D., UNIVERSITY OF MASSACHUSETTS, AMHERST, MA, USA

Directed by: Professor Hang Xiao
Inflammatory bowel disease (IBD) has posed serious threats to the human health,
which lead to chronic malabsorption of nutrients, abnormal pain and rectal bleeding. Both
genetic predisposition and environmental factors contribute to the onset of IBD.
Multiple studies suggested that dysbiosis in colon plays an important role in the
development of colitis, and gut microbiota composition are different between patients
with IBD and healthy individuals. Intake of whole foods, such as fruits and vegetables,
may confer health benefits to the host. The beneficial effects of fruits and vegetables
mainly attribute to their richness of polyphenols and microbiota-accessible carbohydrates
(MACs). Components in fruits and vegetables modulate composition and associated
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functions of the gut microbiota, while gut microbiota can transform components in fruits
and vegetables to produce metabolites that are bioactive and important for health.

Accumulating evidence suggests that colonic inflammation may be prevented by
increased consumption of certain fruits and vegetables such as berries. Cranberry and
strawberry are abundant of polyphenols with various health benefits. Most studies
focused on extractable polyphenols (EP), non-extractable polyphenols (NEP) were often
neglected, although NEP may possess important biological functions. NEP is not
significantly released from the food matrix during digestion in the stomach or small
intestine, therefor they reach colon nearly intact. In the colon, the potential interaction
between gut microbiota and NEP could also play an important role in colon health. NEP
could be biotransformed by gut microbiota to produce bioactive metabolites that may
contribute to the promotion of colon health as well. Therefore, it is important to
investigate the interaction of gut microbiota and NEP in the colon in terms of production
of bioactive metabolites. Meanwhile, composition and functions of gut microbiota can be
altered by the presence of polyphenols in the colon, which in turn could affect colon
health. The objective of this work was to characterize EP and NEP fractions from whole
cranberry and strawberry and determine their potential in anti-inflammation and anticolon cancer. EP and NEP from cranberry and strawberry showed anti-inflammatory
effects in inhibiting LPS-induced production of nitric oxide in macrophages, which was
accompanied by decreased expression of iNOS and increased expression of HO-1. EP
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and NEP from cranberry and strawberry showed anti-cancer capacities in HCT116 cells.
Flow cytometry analysis demonstrated that NEP caused a cell cycle arrest and induced a
significant cellular apoptosis in colon cancer cells.

Furthermore, this study determined the protective effects of whole strawberry
(WS) against dextran sulfate sodium (DSS)-induced colitis in mice. In colitic mice,
dietary WS reduced the disease activity index (DAI), prevented the colon shortening and
spleen enlargement, and alleviated the colonic tissue damages. The abundance of proinflammatory immune cells was reduced by dietary WS in the colonic mucosa, which
was accompanied by the suppression of overproduction of pro-inflammatory cytokines.
Western blotting and immunohistochemical analysis revealed that dietary WS decreased
the expression of pro-inflammatory proteins in the colonic mucosa. Moreover, dietary
WS partially reversed the alteration of gut microbiota in the colitic mice by increasing the
abundance of potential beneficial bacteria, e.g. Bifidobacterium and Lactobacillus, and
decreasing the abundance of potential harmful bacteria, e.g. Dorea and Bilophila. Dietary
WS also restored the decreased production of short chain fatty acids (SCFAs) in the
cecum of the colitic mice. The results revealed the anti-inflammatory effects and
mechanisms of dietary WS in the colon, which is critical for the rational utilization of
strawberry for the prevention of inflammation-driven diseases.
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CHAPTER 1

INTRODUCTION

Trillions of microorganisms inhabit in the large intestine. The main phyla are
Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria and
Verrucomicrobia [1]. In recent years, studies about gut microbiota are blooming. An
increasing number of diseases, such as obesity, inflammatory bowel disease,
cardiovascular diseases, and metabolic syndrome, have been associated with abnormality
in gut microbiota. Gut microbiota could be profoundly influenced by many factors, such
as diet and health status [2]. Modulation of gut microbiota by diet is a promising and
effective way to benefit the host. The effects of diet on the composition and function of
gut microbiota can be beneficial or harmful. In general, dietary intake of whole fruits and
vegetables has been known to beneficially affect gut microbiota by promoting the growth
of beneficial bacteria and/or inhibiting the growth of the harmful bacteria (Figure 1).
Fruits and vegetables are rich in microbiota-accessible carbohydrates (MACs), such as
oligosaccharides, pectin, cellulose, inulin, lignans, and resistant starches, that serve as
substrate for certain beneficial bacteria [3, 4]. Microflora ferments MACs to produce
short-chain fatty acids (SCFAs), which in turn impact bacterial composition. On the other
hand, polyphenols in fruits and vegetables can be degraded by gut bacteria to various
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metabolites, and both polyphenols and their metabolites can modulate gut microbiota.
This review focus on the effects of whole foods, e.g., fruits and vegetables on gut
microbiota and microbiota-associated disease, e.g., obesity and colonic inflammation.

Inflammatory bowel disease (IBD) has posed serious threats to the human health
[5], which lead to chronic malabsorption of nutrients, abnormal pain and rectal bleeding.
Both genetic predisposition and environmental factors contribute to the onset of IBD [6].
Pathological immune response against exotic antigen and bacterial drives the progression
of IBD [7]. Multiple studies suggested that dysbiosis in colon plays an important role in
the development of colitis, and gut microbiota composition are different between patients
with IBD and healthy individuals [8]. The incidence of colonic inflammation has also
been associated with dietary patterns through the modification of gut microbiota [9]. The
diet with high fat, high sugar, high protein and low fiber has been proposed to increase
the risk of IBD. In contrast, dietary consumption of fruits and vegetables has been
associated with lowered risk of IBD [10].

Accumulating evidence suggests that colonic inflammation may be prevented by
increased consumption of certain fruits and vegetables such as berries [10, 11]. Berries
(e.g. chokeberry, red raspberry, strawberry, cowberry) and their extracts have been shown
to have anti-inflammatory and anticancer effects in intestine in various animal models
such as azoxymethane-induced rat colon cancer model, Apc 1638+/- mouse and Muc2-/2

mouse model, and DSS-induced colitis models [12-14]. Polyphenols are a major class of
dietary phytochemicals which are responsible for many health benefits. Current research
on dietary polyphenols mainly focus on a fraction of polyphenols, known as extractable
polyphenols (EP) [15, 16]. EP can be extracted from food with aqueous-organic solvents
(e.g. water, methanol, ethanol, acetone) [17, 18], and are often considered as “total
phenolic content” for various biological studies. However, another fraction of
polyphenols remains in the residues after solvent extraction, and they are known as nonextractable polyphenols (NEP) [16, 19]. NEP are mainly polyphenols that bound to
dietary fiber or other macromolecules through hydrophobic interaction, hydrogen
bonding and covalent bonding [15, 16]. NEP is not significantly released from the food
matrix during digestion in the stomach or small intestine, therefor they reach colon nearly
intact [20]. In the colon, NEP may be released from food matrix by the action of
microbiota and become bioavailable and bioactive. In contrast, EP tend to be absorbed
and metabolized in the upper gastrointestinal tract, therefore, their biological fate is quite
different from that of NEP. Only unabsorbed EP and their metabolites could reach the
colon. The better colonic bioavailability of NEP than EP makes NEP promising
candidates for promoting colon health.

Cranberry is a native berry fruit of North America, and it is abundant of polyphenols
including flavan 3-ols, proanthocyanidins, anthocyanins and phenolic acids [21].

3

Majority of studies on cranberry have been focused on its antibacterial actions [22]. To
date, the inhibitory effects of cranberry on colonic inflammation and colon cancer have
not been adequately studied. Cranberry extracts have been shown to inhibit colon cancer
cell growth and suppress pro-inflammatory enzymes expression [21]. Strawberry is one
of the most popular berry fruits, which is abundant in polyphenols that have been
associated with anti-oxidation, anti-inflammation and anti-cancer bioactivities.
Strawberry juice exhibited anti-inflammatory effects in lipopolysaccharide-treated
macrophage by decreasing the production of pro-inflammatory cytokines [23], and
inhibited the cell proliferation of human colon cancer cell lines [17]. A human study
showed that consumption of strawberry could increase the serum antioxidant capacity
[24]. The consumption of strawberry beverage was associated with the amelioration of
postprandial inflammatory response [25]. These evidences suggested the promising
bioactivity of berry fruits against the colonic inflammation. Whole strawberry contains
vitamins, flavonoids, phenolic acids, anthocyanins, polysaccharides and fiber [17], which
may exhibit stronger anti-inflammatory effects when compared to the extracts. However,
there is no detailed mechanistic information available on the potential protective effects
of whole strawberry against IBD.
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CHAPTER 2

LITERATURE REVIEW

Trillions of microorganisms inhabit in the large intestine. The main phyla are
Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria and
Verrucomicrobia [1]. In recent years, studies about gut microbiota are blooming. An
increasing number of diseases, such as obesity, inflammatory bowel disease,
cardiovascular diseases, and metabolic syndrome, have been associated with abnormality
in gut microbiota. Gut microbiota could be profoundly influenced by many factors, such
as diet and health status [2]. Modulation of gut microbiota by diet is a promising and
effective way to benefit the host. The effects of diet on the composition and function of
gut microbiota can be beneficial or harmful. In general, dietary intake of whole fruits and
vegetables has been known to beneficially affect gut microbiota by promoting the growth
of beneficial bacteria and/or inhibiting the growth of the harmful bacteria (Figure 1).
Fruits and vegetables are rich in microbiota-accessible carbohydrates (MACs), such as
oligosaccharides, pectin, cellulose, inulin, lignans, and resistant starches, that serve as
substrate for certain beneficial bacteria [3, 4]. Microflora ferments MACs to produce
short-chain fatty acids (SCFAs), which in turn impact bacterial composition. On the other
hand, polyphenols in fruits and vegetables can be degraded by gut bacteria to various
metabolites, and both polyphenols and their metabolites can modulate gut microbiota.
5

This review focus on the effects of whole foods, e.g., fruits and vegetables on gut
microbiota and microbiota-associated disease, e.g., obesity and colonic inflammation.

Figure. 1 The interactions between whole foods and gut microbiota. Whole foods such as
fruits and vegetables are rich in microbiota-accessible carbohydrates and polyphenols.
microbiota-accessible carbohydrates, such as oligosaccharides, pectin, cellulose, inulin,
lignans, and resistant starches, are resistant to digestion in the upper gastrointestinal tract
prior to reaching the large intestine where they interact with gut microbiota. This
interaction may lead to (i) altered gut microbiota, and (ii) the production of short-chain
6

fatty acids from fermentation of microbiota-accessible carbohydrates by microbiota, and
short-chain fatty acids may also modulate microbiota composition. After consumption of
whole fruits and vegetables, a large portion of their polyphenols accumulate in the large
intestine where they may interact with gut microbiota to (i) modify the structure of
microbial community, and (ii) produce bioactive metabolites, such as phenolic acids, via
microbiota-mediated metabolism of polyphenols. The microbial metabolites of
polyphenols could modulate gut microbiota as well. The overall outcome of interactions
between whole foods and gut microbiota may be an increased abundance of beneficial
bacteria and a decreased abundance of harmful bacteria. Moreover, short-chain fatty acids
and phenolic acids may also interact with host tissues such as colonic epithelia to impact
host health.
2.1 Interactions between Whole Foods and Gut Microbiota in Disease-free Populations

Whole fruits and vegetables are known to be good food choices to maintain and
promote health. Various fruits and vegetables have been studied to determine their effects
on gut microbiota in healthy, disease-free populations including both humans and
animals. This section provided a summary of the modulating effects of fruits and
vegetables on gut microbiota, as well as the interactions between gut microbiota and the
major bioactive components of fruits and vegetables. Table 1 summarized representative
studies on the impacts of whole foods and their components on gut microbiota.
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Table 1. Effects of whole fruits and vegetables on gut microbiota in disease-free populations.
Source

apple

Whole foods
or extracts

model

Dose

Fresh apple

human

Oral, 2 apples/
person/day

2 weeks

↑Bifidobacterium,
↑Streptococcus,
↓Pseudomonas

Raw whole
apple

rats

Oral, 10 g/day

4 weeks

↓Bacteroides
[27]

Apple pectin

black
raspberry

freeze‐dried
black
raspberries
powder
freeze‐dried
black
raspberries
powder
freeze‐dried
black
raspberries
powder
anthocyanins
from black
raspberry
residues
fraction from
black raspberry

Duration Effects on gut microbiota

Reference

↑Lactobacillus,
↓Enterobacteriaceae,

[26]

rats

Oral, 7% pectin

4 weeks

↑Anaeroplasma, ↑Anaerostipes, ↑Roseburia,
↑Clostridium
coccoides,
↓Alistipes,
↓Parabacteroides sp, ↓Bacteroides

mice

Oral, 10% w/w

6 weeks

↓Clostridium, ↓Lactobacillus, ↑Barnesiella,

[28]

mice

Oral, 10% w/w

7 weeks

↓Firmicutes,
↑Bacteroidetes,
↑Verrucomicrobia, ↑Akkermansia muciniphila

[29]

rats

Oral, 5% w/w

6 weeks

↑Anaerostipes, ↑Akkermansia, ↑Desulfovibrio,
↑Ruminococcus, ↑Coprpbacillus, ↓Acetivibrio

rats

Oral, 0.2% w/w

6 weeks

↑Anaerovorax,
↓Lactococcus

rats

Oral, 2.25% w/w

6 weeks

↑Anaerostipes,
↑Desulfovibrio,
↑Coprobacillus, ↑Victivallis, ↑Mucispirilum,
↓Streptococcus, ↓Turicibacter, ↓Acetivibrio
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↑Dorea,

↓Bifdobacterium,

[30]

blueberry

wild blueberry
drink (25 g of
wild
blueberry
powder in 250
mL of water)
Lowbush wild
blueberries
powder
(Vaccinium
angustifolium)
freeze‐dried
blueberry
powder
water-soluble
blueberry
extracts
Freeze-dried
blueberry
(Vaccinium
angustifolium)
pomace
powder

human

Oral, 25
g/day/person

6 weeks

↑Bifidobacterium spp.

[31]

rats

Oral, 8% w/w

6 weeks

↑Bifidobacteriaceae,
↑Coriobacteriaceae,
↓Lactobacillus, ↓Enterococcus

[32]

mice

Oral, 5% w/w

4 weeks

↑Tenericutes, ↓Deferribacteres

[33]

rats

Gavage, 4 ml of
extracts/kg body
weight/day

6 days

↑Lactobacilli, ↑Bifidobacteria

[34]

chicken

Oral, 1% and 2%
w/w

64 days

↑Bacteroidetes,
↑Lactobacillus,
↑Bifidobacterium,
↓Escherichia
coli,
↓Clostridium_Clostridiaceae, ↓Helicobacter,
↓Enterococcus

[35]
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cherry

citrus

cranberry

cherry
concentrate
juice

human

Oral, 8 oz/day

5 days

citrus pectin

mice

orange juice

human

Oral, 15% w/w
Oral, 300
mL/day/person

4 weeks
2
months

human

Oral, 500
mL/day/persom

human

orange juice
(Citrus
sinensis)
freeze-dried
whole
cranberry
powder
cranberry juice

kiwifruit

freeze-dried
green kiwifruit
powder
(without peel)
freeze-dried

high-Bacteroides individuals: ↓Bacteroides,
↓Parabacteroides, ↓Alistipes, ↓Barnesiella,
↓Butyricimonas,
↓Odoribacter,
↓Porphyromonas,
↓Bifidobacterium,
↑Ruminococcus,
↑Lachnospiraceae,
↑Clostridium, ↑Clostridium XI, ↑Dialister,
↑Coprococcus, ↑Lactobacillu, ↑Streptococcus.
low-Bacteroides
individuals:
↓Lachnospiraceae, ↓Streptococcus, ↓Dialister,
↓Blautia,
↓Roseburia,
↑Bacteroides,
↑Prevotella, ↑Alistipes, ↑Clsotridium IV and
XI,
↑Lactobacillus,
↑Bifidobacterium,
↑Ruminococcus
↑Bacteroidetes, ↓Firmicutes

[36]

[37]

↑Lactobacillus spp., ↑Bifidobacterium spp.

[38]

7 days

↑Mogibacteriaceae,
↑Lachnospiraceae,
↑Ruminococcaceae,
↑Veillonellaceae,
↑Enterococcaceae, ↑Coriobacteriaceae

[39]

Oral,
30g/day/person

5 days

↓Firmicutes, ↑Bacteroidetes

[40]

human

Oral,
200mL/day/person

3 weeks

↓Helicobacter pylori

[41]

pigs

Oral, 25% w/w

14 days

↑Bacteroides, ↓Enterobacteria, ↓Escherichia
coli

[42]

pigs

Oral, 6.9% w/w

14 days

↑Bacteroides

10

Hardy
banana

green kiwifruit
fiber powder
freeze-dried
green kiwifruit
(A. deliciosa)
powder
(without peel)
freeze-dried
gold kiwifruit
(A. chinensis)
powder
(without peel)
freeze-dried
Musa basjoo
powder
(dissolved in
20 mL ddH2O)
pomegranate
extract

pomegranate

broccoli

pomegranate
(Punica
granatum L.
Mollar de
Elche
cv.) juice
Cooked
broccoli

rats

Oral, 10% w/w

4 weeks

↑Lachnospiraceae
[43]

rats

Oral, 10% w/w

4 weeks

↑Bacteroides–Prevotella–Porphyromonas
group, ↑Enterococcus spp.

mice

Gavage, 0.52,
1.04, 2.07 g/kg
bw/day

7 weeks

↑Bacteroides, ↑Roseburia, ↓Staphylococcus,
↓Helicobacter

[44]

[45]

human

Oral, 1000
mg/day/person

4 weeks

↑Actinobacteria, ↑Butyrivibrio, ↑Enterobacter,
↑Escherichia, ↑Lactobacillus, ↑Prevotella,
↑Serratia,
↑Veillonella,
↓Firmicutes,
↓Collinsella

human

Oral, 200
mL/day/person

4 weeks

no significant changes of microbiota

[46]

human

Oral, 200
g/day/person

15 days

↑Bacteroides, ↑Bacteroidetes, ↓Firmicutes

[47]

11

mushroom

soybean

freeze-drying
broccoli
powder
Dried
Armillariella
tabescens
powder
freeze-dried
white button
mushroom
powder
(Agaricus
bisporous)
freeze-dried
white button
mushroom
powder
freeze-dried
Pleurotus
eryngii powder
soybean flour
soy fiber

rats

Oral, 10% w/w

4 days

↑Akkermansia, ↑Oscillspira, ↓Clostridium,
↓Dorea

[48]

pigs

Oral, 0.1, 0.3, and
0.9% w/w

30 days

↑Lactobacillus spp., ↑Bifidobacterium spp.,
↓Escherichia coli

[49]

mice

Oral, 1% w/w

4 weeks

↑Bacteroidetes, ↓Clostridia, ↓Firmicutes

[50]

pigs

Oral, 3 and 6
serving size

6 weeks

↑Lachnospiraceae,
↑Ruminococcaceae,
↑Porphyromonadaceae, ↓Bifidobacteriaceae

[51]

mice

Oral, 1 and 3%
w/w

6 weeks

↑Bacteroidetes,
↑Deferribacteres,
↓Firmicutes, ↓Verrucomicrobia

[52]

rats

Oral, 41.5% w/w

14 days

↑Prevotella, ↑Eubacterium
↑Prevotella,
↑Erysipelotrichaceae,
↓Adlercreuzia,

[53]

rats

Oral, 2.0% w/w

14 days
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↑Bacteroidales,
↓Clostridiaceae,

2.1.1 Whole Fruits and Vegetables Beneficially Impact Gut Microbiota

Among the major phyla of gut microbiota, Firmicutes and Bacteroidetes represent
more than 90% of the phylogenetic types [1, 54]. Intake of whole fruits and vegetables
could modulate the growth of Firmicutes and Bacteroidetes. A lowered ratio of
Firmicutes to Bacteroidetes (F/B) is considered as a marker of healthier gut microbiota
[28]. Daily consumption of 200 g of cooked broccoli for 18 days in human volunteers
reduced the relative fecal abundance of Firmicutes and increase that of Bacteroidetes.
These effects were ascribed to fiber and glucosinolates found in broccoli [47]. Human
intake of cranberry (30 grams of freeze-dried powder per day for 5 days) also led to a
decrease in the fecal abundance of Firmicutes and an increase in Bacteroidetes.
Consistent with these human studies, dietary treatment with freeze-dried black raspberry
powder (10% w/w in diet) to mice for 6 weeks lowered the F/B ratio in the fecal
microbiota [28]. Feeding of cooked navy bean or black bean to mice altered fecal
microbiota structure showing an increasing trend in the abundance of Bacteroidetes. The
fecal abundance of S24-7, a major family of Bacteroidetes, was significantly increased,
and the fecal abundance of Oscillospira, Ruminococcus gnavus, Lactococcus,
Coprococcus and Streptococcus, all members from Firmicutes, were remarkably
decreased by the intake of the beans. Moreover, concomitant with the altered fecal
microbiota, dietary bean treatments enhanced multiple aspects of mucus and epithelial
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barrier integrity in the mouse colon [55].

Intake of whole fruits and vegetables can promote the growth of certain beneficial
bacteria, such as Bifidobacterium and Lactobacillus. In human studies, oral intake of
freeze-dried wild blueberry powder increased fecal abundance of Bifidobacterium and
Lactobacillus [31, 56]. After simulated digestion, fermentation of whole apples (Renetta
and Golden Delicious) with fecal bacteria from healthy donors promoted the growth of
Bifidobacterium [57]. Whole foods also modulate gut microbiota through inhibiting
potential harmful microorganisms. Cranberry intake (freeze-dried whole cranberry
powder, 30 g/day for 5 days) in humans decrease the fecal abundance of bacteria that
were associated with infection and antibiotic resistance, such as Clostridia and
Oribacterium [40, 58]. Consumption of 2 apples per day for 2 weeks in human volunteers
decreased the fecal abundance of lecithinase-positive clostridia, including C. perfringens,
a potential pathogen for food poisoning [26]. Whole foods intake also showed inhibitory
effects on potential harmful bacteria in animal models. Lingonberries in diet (20% w/w)
caused a decrease in fecal abundance of Lachnospiraceae, Ruminococcus and
Oscillospira in mice. These microorganisms were linked to obesity and type II diabetes
[59]. Oral administration of bitter melon (freeze-dried powder without seeds) to rats
decreased the proportion of the potential endotoxin-producing opportunistic pathogens,
such as Escherichia, in the fecal microbiota [60]. Dietary treatment with green kiwifruit
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(freeze-fried powder) decreased the fecal abundance of Escherichia coli [42], and feeding
white mushroom (Freeze-dried powder) to mice decreased fecal abundance of Clostridia
[50].

It is well recognized that there are considerable inter-individual variations in gut
microbiota among humans. The difference in the gut microbiota composition may also
render the individuals difference in responding to the same dietary intervention. For
example, intake of tart cherry juice induced distinct and inverse responses in gut
microbiota among human participants who had different initial levels of Bacteroides prior
to the dietary intervention [36]. After tart cherry juice consumption, low-Bacteroides
participants showed a decrease in Lachnospiraceae, Ruminococcus and Collinsella, and
an increase in Bacteroides and Bifidobacterium, whereas, high-Bacteroides participants
showed opposite changes in fecal microbiota compared to that in low-Bacteroides
participants, i.e., an increase in Lachnospiraceae, Ruminococcus and Collinsella, and a
decrease in Bacteroides and Bifidobacterium [36]. The mechanism underlying the
interesting phenomena warrants further investigation.

The beneficial alterations of gut microbiota induced by whole fruits and
vegetables were mainly attributed to microbiota-accessible carbohydrates (MACs) and
polyphenols found in these whole foods [4]. The interactions between gut microbiota,
MACs, and polyphenols were discussed below.
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2.1.2 Interaction between Microbiota-Accessible Carbohydrates (MACs) and Gut
Microbiota

MACs are indigestible by host-secreted intestinal enzymes and therefore, reach
the colon largely intact, where they serve as substrates for certain gut bacteria [3]. Fruits
and vegetables are generally abundant in multiple types of MACs, such as
oligosaccharides, pectin, cellulose, inulin, lignans, and resistant starches [61]. Gut
microbiota is dominated by phyla of Firmicutes and Bacteroidetes, both of which contain
bacteria that can utilize MACs [62]. MACs interact with bacteria in the colon, resulting in
favoring or inhibiting the growth of specific bacteria. For example, availability of MACs
promotes the growth of certain beneficial bacteria that can readily utilize these MACs as
energy sources, whereas the bacterium-derived metabolites of MACs, such as SCFAs,
can inhibit the growth of certain harmful bacteria. Consequently, composition of gut
microbiota can be shaped by availability or unavailability of MACs in the colon. For
example, Low intake of MACs resulted in a remarkable decrease of taxa and diversity of
gut bacteria relative to high intake of MACs in humanized mice [4]. High intake of
MACs was associated with increased fecal richness of Bacteroidetes, especially the
Prevotella, and depletion of Firmicutes in healthy children. Moreover, children who
consumed high levels of MACs had higher levels of fecal SCFAs, which was associated
with the lower abundance of fecal pathogens, such as Escherichia and Shigella [63].
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Apples are abundant in pectin, a soluble fiber [64]. Consumption of 2 apples per day in
human subjects increased fecal abundance of beneficial bacteria Bifidobacterium and
Lactobacilli, elevated production of SCFAs, and decreased abundance of potential
harmful bacteria Enterobacteriaceae and Pseudomonas [26]. In vitro fermentation of
apple pectin with human fecal bacteria facilitated the growth of Bifidobacterium and
Lactobacillus, suggesting that pectin in apples was, at least in part, responsible for the
improved gut microbial ecosystem observed in the apple-eating human subjects [26].
Moreover, consumption of citrus pectin (15% w/w in the mouse diet) also led to
increased fecal abundance of Bacteroidetes and decreased abundance of Firmicutes [37].
Cranberry is rich in fibers. A randomized crossover controlled trial demonstrated that
daily intake of 30 grams of freeze-dried whole cranberry powder (equivalent to 2.3 cups
of fresh cranberry) in humans led to a lowered F/B ratio in fecal microbiota [40]. These
effects might be partially due to the action of cranberry fiber because that cranberryderived soluble fiber xyloglucans could support the growth of Bifidobacterium longum, a
beneficial bacterium [65]. Studies in rodents also supported the role of MACs in
modulating gut microbiota. Six weeks of dietary treatment of fiber-rich white-button
mushrooms increased the abundance of Ruminococcaceae and Lachnospiraceae families
in mouse fecal microbiota [51]. Bacteria from these two families were known to be able
to utilize plant fibers to produce SCFAs [66, 67]. Additionally, oral administration of
broccoli and potato fiber significantly increased the fecal abundance of Bacteroides,
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Prevotella and Porphyromonas in rats, and importantly, intake of broccoli fiber decreased
the abundance of the potential pathogens, such as Clostridium perfringens, Escherichia
coli and Enterococcus spp. [68]. Fiber-rich diet can inhibit the growth of pathogens,
through the change of pH environment induced by the production of SCFAs [63, 69].
Increased microbial diversity is a marker of healthier gut microbiota [28]. Hardy banana
(Musa basjoo) is rich in resistant starch [70]. Consumption of dried hardy banana powder
(rich in resistant starch) in diet for 3 weeks led to higher α-diversity and β-diversity, as
well as a decreased ratio of Firmicutes to Bacteroidetes of fecal microbiota in mice [44].
These effects could be ascribed to resistant starch in hardy banana. In support of this
notion, a 17-week double-blind crossover human study demonstrated that daily intake of
33 g resistant starch (resistant starch types 4) for three weeks increased the fecal
abundance of Bacteroidetes and lowered the fecal abundance of Firmicutes [71].

One of the major functions of gut microbiota is to ferment MACs to produce
SCFAs primarily including acetate, propionate and butyrate. Members from
Bacteroidetes and Firmicutes produce various enzymes capable of breaking down MACs
to yield SCFAs, and SCFAs could positively influence gut microbiota and host gut health.
The higher fecal levels of SCFAs in children consuming high amount of MACs were
associated with lower abundance of pathogens [63]. In line with this study, a randomized,
double-blind, placebo-controlled, parallel-group human trial showed that enema with
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sodium butyrate during shigellosis led to improvement of rectal histopathology and early
reduction of inflammation [72]. Furthermore, oral administration of sodium butyrate (200
mg/kg body weight ) to mice remarkably increased the fecal abundance of potential
beneficial bacteria, such as Christensenellaceae, Blautia and Lactobacillus [73]. SCFAs
play important roles in the gut health. The production of SCFAs is a means of recovering
energy for host body, for example, acetate can be absorbed by the liver and server as
substrate for the cholesterol synthesis [74]. Importantly, SCFAs possess biological
activities beneficial to the host. Dietary supplementation of SCFAs in obese rodents or
humans was shown to result in promising beneficial effects. Administration of butyrate
(5% w/w) to mice inhibited high-fat diet-induced body weight gain and insulin resistance,
and butyrate treatment also promoted energy expenditure [75]. Oral intake of inulinpropionate ester, a means of delivery of propionate to the colon, for 24 weeks in humans
prevented the weight gain in overweight humans [76].

2.1.3 Interactions between Polyphenols and Gut Microbiota

Polyphenols are abundant in whole fruits and vegetables, and they play important
roles in improving the gut microbial community. Polyphenols (such as catechins) can be
absorbed in the small intestine, and a significant portion of them are metabolized and
excreted back to the intestinal lumen via efflux pump in the intestinal epithelium and bile
secretion from liver. Conjugated and polymeric polyphenols (such as anthocyanins and
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proanthocyanidins) have low absorption in the upper gastrointestinal tract and a large
portion of them accumulate in the colon. In general, abundant amount of dietary
polyphenols reach the colon intact or in the forms of their metabolites [77]. Polyphenols
and their metabolites interact with microbiota in the colon in a reciprocal manner as
bacteria can metabolize these compounds, and these compounds can modulate microbiota
composition and functions. This reciprocal interaction has been linked to improved host
health.

2.1.3.1 The Impact of Gut Microbiota on Polyphenols.

The biotransformation of polyphenols by gut microbiota in the colon has been
extensively studied in recent years. Various metabolites have been identified, and they may
have different biological functions in comparison to their parent polyphenol compounds.
This is the reason why biotransformation of polyphenols by gut microbiota could play an
important role in mediating health effects of dietary polyphenols. For example, flavonoid
glycosides can be transformed to aglycon that are generally more bioavailable and more
bioactive. Fission reactions mediated by gut bacteria lead to the breakdown of the ring
structures of polyphenols and production of various phenolic acids that convey bioactivities
not offered by the intact polyphenols.

Although the chemical natures of polyphenols are diverse and complex, they can
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be broken down by gut microbiota to form much simpler structures such as derivatives of
phenylacetic, phenylpropionic, phenylbutiric, valeric acids and urolithins [78-80].
Feeding freeze-dried powders of cranberry, blueberry or black raspberry to rats resulted
in urinary excretion of about 20 different phenolic acids with hippuric, 4hydroxyphenylacetic and 4-hydroxy-3-methoxyphenylacetic, and 4hydroxyphenylpropioic acids being major ones [81]. The production of these phenolic
acids was ascribed to the microbial breakdown of polyphenols in those berries, and the
relative urinary abundance of different phenolic acids was dependent on berry types. The
production of potential microbial metabolites of berry polyphenols was also investigated
in humans, and the results showed similarity as well as difference between rodents and
humans in response to dietary consumption of whole berries. Oral intake of wild
blueberry powder (22 grams per day) in humans for 30 days significantly increased
plasma levels of benzoic, 2,5-dihydroxybenzoic, vanillic, hippuric, and 3-hydroxyhipuric
acids, while no significant change was observed in the urinary levels of these metabolites
[46, 82]. In contrast, the urinary level of hippuric acid was increased about 6-fold while
those of 2,5-dihydroxybenzoic and vanillic acids did not change after oral intake of
blueberry powder in rats [81]. In another human study, consumption of cranberry powder
(30 grams per day) for 5 days increased urinary levels of 3,4-dihydroxyphenylacetic and
4-hydroxy-3-methoxyphenylacetic acids [40], whereas, cranberry-fed rats showed
increased urinary level of 4-hydroxy-3-methoxyphenylacetic acid, but not that of 3,421

dihydroxyphenylacetic acid [81]. The difference in microbial metabolites of berry
polyphenols between rodents and humans may be attributed to their differences in gut
microbiota composition and host metabolism of polyphenols. Besides phenolic acids,
many other types of microbiota-derived polyphenol metabolites have been or yet to be
identified. Their contributions to human health is an important topic, which warrants
further investigation.

To better understand the mechanism of microbiota-mediated biotransformation of
polyphenols, it is important to identify the strains of bacteria and their genes/enzymes
responsible for the production of specific metabolites of polyphenols. For example,
colonic bacteria could produce multiple enzymes responsible for various deconjugation
reactions of polyphenols, such as β-glucuronidase [83, 84], β-glucosidase [85], esterases
[86], hydrogenases [87], dehydroxylase [85, 88] and demethylase [85, 88, 89].
Eubacterium ramulus and Clostridium saccbarogumia were able to convert cyanidin 3glucoside, a common anthocyanin from berry fruits to 3,4-dihydroxybenzoic acid and
2,4,6-trihydroxybenzaldehyde [90]. Streptococcus thermophiles and Lactobacillus
plantarum broke down mulberry anthocyanins to form chlorogenic acid, caffeic acid and
ferulic acid [91]. Bifidobacterium lactis and Lactobacillus gasseri produced cinnamoyl
esterase that converted chlorogenic acid to hydroxycinnamate and ferulic acid [92].
Although information on specific gut microorganism and their genes responsible for the
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production of bioactive polyphenol metabolites is accumulating, the overall
understanding of this subject remains preliminary, which significantly limited our ability
to elucidate the complex interplay between dietary components and gut microbiota.

2.1.3.2 Modulation of gut microbiota by polyphenols from whole fruits and vegetables

As a class of major bioactive components of fruits and vegetables, polyphenols
could modulate gut microbiota through stimulation of beneficial bacteria and inhibition
of pathogens. The effects of polyphenol-rich extracts of fruits and vegetables on gut
microbiota have been studied in humans and animals. The administration of 1% (w/w in
diet) of grape seed extract in pigs for 6 days altered gut microbiota composition, i.e.,
increased abundance of potential beneficial bacteria, such as Lachnospiraceae,
Ruminococcaceae, and Lacobacillus [93]. Lachnospiraceae and Ruminococcaceae are
two families of bacteria in the order Clostridiales that could produce short-chain fatty
acids by fermenting dietary fiber, thereby potentially promoting intestinal health [94].
The early-life supplementation of a grape pomace extract (200 mg/Kg·bw by daily
gavage for 12 days) in mice caused an inhibition of norank_f_Lachnospiraceae,
unclassified_f_Lachnospiraceae, Mucispirillum as well as promotion of Akkermansia and
Lactobacillus in the fecal microbiota [95]. Mucispirillum is considered a commensal with
association to the increase of inflammatory biomarkers and colitis [96]. Some members
of Lachnospiraceae were linked to diet-induced obesity and positively correlated with
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diabetes [97, 98]. Oral gavage of a bilberry anthocyanin extract (20 mg/kg bw per day for
10 weeks) to rats increased the fecal abundance of some bacteria potentially beneficial to
the host, such as Aspergillus, Lactobacillus, Bacteroides, Clostridiaceae-1, the
Bacteroidales-S24-7-group and the Lachnospiraceae_NK4A136_group, and at the same
time reduced the abundance of potential harmful bacteria, such as Verrucomicrobia and
Euryarchaeota [99]. Furthermore, thirty-nine postmenopausal women consumed 100 mg
of dietary isoflavones daily for two months to characterize changes in microbial
communities of the intestinal tract. The supplementation elevated the abundance of
dominant microorganisms of the Clostridium coccoides-Eubacterium rectale cluster,
Lactobacillus-Enterococcus group, and Bifidobacterium genus, and these organisms were
considered beneficial to the human health in various aspects [100]. The lower ratio of
Firmicutes to Bacteroidetes implicates a non-obese and healthier status. The consumption
of a grape seed proanthocyanidin extract (500 mg/kg bw, daily gavage for 8 days) could
increase the cecal abundance of Bacteroidetes and Proteobacteria and decreased the F/B
ratio in rats [101]. In a human study, twenty healthy participants were supplemented with
1000 mg of a pomegranate extract daily for four weeks, which delivers pomegranate
polyphenols in an amount equivalent to about 8 oz of pomegranate juice. It was observed
that the pomegranate extract significantly decreased the fecal abundance of Firmicutes.
[45].
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The metabolites of polyphenols produced by microorganisms in the large intestine
could also impact gut microbiota. Yersinia enterocolitica is an enteropathogen to humans
and mammals and causes gastrointestinal infections after the consumption of
contaminated foods [102]. Urolithins are gut microbiota-derived metabolites of ellagic
acid. Urolithin-A and urolithin-B inhibited Quorum Sensing-mediated processes such as
biofilm formation and swimming motility in Y. enterocolitica, which suggested that
urolithins may exert antipathogenic affect against Y. enterocolitica in the gut [103]. It is
important to point out that the aforementioned antipathogenic effects of urolithins were
observed at the concentrations of urolithins achievable in the intestinal tract through
regular diet.

2.2. Whole Foods vs. Isolated Major Components of Whole Foods in Modulating Gut
Microbiota

2.3. Whole Foods and Gut Microbiota-associated Diseases

2.3.1 Obesity

Gut microbiota is a critical factor in the development of obesity. Lacking of gut
microbiota in germ-free mice resulted in a resistance to the Western diet-induced obesity
[108], indicating a pivotal role of gut microbiota in obesity. Microorganisms that inhabit
in the large intestine can ferment MACs and produce SCFAs that are absorbed and
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provide energy supply for the host [109]. Higher energy intake than expenditure could
lead to obesity, and the obesity-associated microbiota were found to have higher capacity
for energy harvest [54]. As the dominant phyla of gut microbiota, both Firmicutes and
Bacteroidetes are capable of degrading MACs to produce SCFAs. A higher ratio of
Firmicute to Bacteroidetes was observed in obese mice and humans [54]. Furthermore,
production of SCFAs in the colon was found to induce obesity by enhancing lipid
synthesis [110]. Dietary intake of whole fruits and vegetables was reported to impact
obesity through the modulation of gut microbiota. Table 2 listed the alteration of gut
microbiota in obese rodents and humans induced by dietary intervention with various
whole fruits and vegetables.

The relative abundance of Firmicutes and Bacteroidetes is considered as an
important marker in the development of obesity. The increase in Firmicutes and decrease
in Bacteroidetes were reported in obese mice and humans with high BMIs [54, 111]. In
genetically obese mice, Bacteroidetes abundance was 50% lower than that in lean mice,
and the microbiota in obese mice was associated with more effective capacity to release
calories than that in lean mice [111]. A human study also showed an inverse correlation
between Bacteroidetes abundance and body weight [111]. Members from Firmicutes
(such as Ruminococcaceae, Lachnospiraceae, Clostridium, and Lactococcus) and
Bacteroidetes (such as Prevotella, Bacteroides, and S24-7) have been frequently studied

26

in terms of their potential contributions to the development of obesity. Consumption of
wholes foods had anti-obesity effects and also resulted in decreases in the abundance of
Firmicutes and its members and increases in the abundance of Bacteroidetes and its
members in obese mice, for example, the decreased abundance of Ruminococcus gnavus
by navy bean [112] and Clostridium by tomato and pomegranate juice [113], and the
increased abundance of Bacteroides by lingonberry and strawberry [114-116], Prevotella
and S24-7 by cherry, lingonberry and navy bean [59, 112, 117].

Although the lowered F/B ratio has been widely used to indicate an anti-obesity
profile of gut microbiota, it is worth mentioning that emerging evidence has supported
the use of other microbiota-related markers to characterize obesity status. Opposite to the
expected low F/B ratio in lean individuals, a human study showed a lowered F/B ratio in
overweight and obese individuals in comparison to that of lean individuals [118]. Fibers
can be fermented by both Firmicutes and Bacteroidetes, such as Lactobacillus and
Ruminococcus from Firmicutes, and Prevotella and S24-7 from Bacteroidetes [119, 120],
thus both Firmicutes and Bacteroidetes could thrive at the presence of fiber-rich whole
foods. For example, oral administration of mushroom powders inhibited obesity in mice,
but it did not lower the F/B ratio [121]. This may be due to the increase of the abundance
of Firmicutes genera Lactobacillus, Lactococcus and Ruminococcus at the presence of
mushroom fibers [121]. Avocado and bitter melon-fed obese rats significantly lost body
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weight, but they did not show a lowered F/B ratio in comparison with the obese rats [60,
122]. These results supported the use of markers other than the F/B ratio to indicate an
anti-obesity microbiota profile. For example, Prevotella-to-Bacteroides ratio was used to
predict the success in weight loss in humans [123]. Interestingly, the amount of fecal
SCFAs has been considered as a marker of obesity in humans because that colonic
production of SCFAs correlated well with the BMI and the levels of SCFAs are in
accordance with the alteration of gut bacteria [118, 124].

As shown in Table 2, Akkermansia, a Gram-negative bacterium belonging to
Verrucomicrobia, has attracted increasing attention in terms of its role in obesity. Calorie
restriction followed by a weight-stabilizing diet improved metabolism status of
overweight and obese volunteers, which was accompanied by higher fecal abundance of
Akkermansia muciniphila [125]. The fecal abundance of Akkermansia muciniphila
inversely correlated with body weight of rodents and humans, and the oral administration
of Akkermansia muciniphila alleviated high-fat diet-induced metabolic disorder, such as
increased fat-mass, inflammation in adipose tissue, metabolomic endotoxemia, and
insulin resistance [59, 112, 117]. Importantly, obesity was associated with the reduced
mucus thickness in mouse intestinal tract [126], suggesting the increased gut
permeability. Akkermansia muciniphila administration in obese mice restored the
thickness of mucus, thus enhancing the gut barrier function, as well as improving glucose
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homeostasis and adipose tissue metabolism [126]. Interestingly, a protein named
Amuc_1100, isolated from outer membrane of Akkermansia muciniphila, was capable of
recapitulating the beneficial effects of Akkermansia muciniphila through the interaction
with Toll -like receptor 2 to improve gut barrier [127].

Consumption of whole fruits and vegetables were found to increase the
abundance of Akkermansia muciniphila. For example, oral intake of cherry [117],
lingonberry [59, 115, 116], grape [128], mango [129], or navy bean [112] in obese mice
decreased body weight and increased the fecal abundance of Akkermansia muciniphila,
indicating that anti-obesity actions of these whole fruits and vegetables might be closely
related to their effects in promoting the growth of Akkermansia muciniphila. The high
levels of fibers in these whole foods might contribute to the blooming of Akkermansia
muciniphila in the colon [130]. Furthermore, dietary polyphenols from fruits also could
promote the growth of Akkermansia muciniphila in the colon, which was associated with
their anti-obesity and anti-colonic inflammation potential [131].
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Table 2. The effects of whole fruits and vegetables on gut microbiota in obesity models
source

animal model

dose

duration

avocado

overweight/obe
se human

Oral, 1
avocado/
day/perso
n

12
weeks

bitter
melon
(Momordi
ca
charantia
L.)

Gavage,
300
high-fat induced
mg/kg
obesity in rat
body
weight/da
y

8 weeks

bitter
melon

high-fat induced
Oral,
obesity in
1.5% w/w
mouse

16
weeks

biomarkers

Effects on gut microbiota

↑Dialister,
↑Sutterella,
decrease in IL-1β, C↑Bilophila,
↑Holdemanella,
reactive
protein
and
↑Herbaspirillum, ↑Acetivibrio;
hepatic growth factor
↓Methanosphaera
↓Proteobacteria,
↓Desulfovibrionaceae,
decrease
in
fasting
↓Enterobacteriaceae,
glucose, HOMA-IR, TNF↓Escherichia,
α, IL-6, MCP-1 and LPS
↑Odoribacteraceae,
concentration, increase in
↑Allobaculum, ↑Butyricimonas,
IL-10
↑Faecalibacterium,
↑Odoribacter
decrease in macrophages ↑Bacteroidetes, ↑Clostridiaceae,
infiltration,
↑Porphyromonadaceae,
sphingokinase1 mRNA, ↑Ruminococcus, ↑Lactobacillus,
IL-1β,
NLRP
3 ↓Firmicutes,
↓Actinobacteria,
inflammasome
↓Eubacteriaceae, ↓Oscillibacter,
components
↓Blautia,

bitter
melon
(Momordi
ca
charantia
L.)

high-fat dietinduced obesity
in rat

Gavage,
400
mg/kg
body
weight/da
y

8 weeks

decrease in
HOMA-IR

blueberry

high-fat diet-fed
Oral,
rat
10 % w/w

8 weeks

increase in ilea villus, ↑Actinobacillus,
Mucin 2, decrease in TNF- ↑Aggregatibacter,
α, IL-1β
↑Fusobacteriaceae,
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LBP

↑Verrucomicrobia,
↑Blautia,
and ↑Anaerotruncus, ↑Lactococcus,
↑Allobaculum, ↑Oceanbacillus,
↓Prevotella, ↓Anaeroplasms.

reference
[122]

[60]

[132]

[133]

[134]

↑Lactobacillales,
↑Porphyromonadaceae

broccoli

grape

high-fat induced
Oral,
obesity in rat
7.5% w/w

17
weeks

high-fat induced
obestiy in
mouse

11
weeks

Oral, 3
and 5%
w/w

Lingonber
ry
high-fat induced
Oral,
(Vacciniu
obesity in
20 % w/w
m vitismouse
idaea L.)

11
weeks

Mango
(Mangifer
a Indica
L.)

obese
individuals

Oral, 400
g/day
/person

6 weeks

mango

high-fat induced
obesity in
mouse

Oral, 1
and 10 %
w/w

12
weeks

mushroom

high-fat induced
obesity in
mouse

Oral, 0.5
and 3 %
w/w

4 weeks

decrease in body weight ↑Bifidobacterium
gain
↑Lactobacillus spp.

spp.,

↓Desulfobacter spp., ↓Bilophila
decrease in body fat and
wadsworthia,
↑Akkermansia
TG, increase in ZO-1
muciniphila
↑Akkermansia,
↑Faecalibacterium,
↑S24-7,
decease in plasma levels of
↑Parabacteriodes, ↑Odoribacter,
glucose and cholesterol,
↓Firmicutes/Bacteroidetes ratio,
serum amyloid and LBP
↓Ruminococcus, ↓Oscillospira,
↓Bacteroides, ↓Lachnospiraceae
trend toward decreased trend
toward
decreased
endotoxin
Bacteroides thetaiotaomicron
increase in IL-10 and
plasma insulin, no effect ↑Bifidobacteria, ↑Akkermansia,
on glucose tolerance and ↑Aldercrutzia
body weight
trend
toward
increased
Allobaculum, Bifidobacterium,
decrease in adipocyte size
Ruminococcus,
Lactobacillus,
and perinephric adipose
Lactococcus and Streptococcus,
tissue
and decreased Bacteroides,
Prevotella,
Mucispirillum,
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[135]

[128]

[59]

[136]

[129]

[121]

Dorea, Roseburia, Escherichia
and Akkermansia

navy bean

high-fat induced
obesity in
mouse

Oral,
15.7%
w/w

12
weeks

spinach

high-fat induced
NAFLD in rat

Oral, 2.5
and 5 %
w/w

5 weeks

increase in ZO-1, occludin
↑Akkermansia
muciniphila,
and mucins; decrease in
↑Prevotella,
↑S24-7,
HOMA-IR, adipocyte size,
↓Ruminococcus gnavus
NFkBp65 and STAT3

[112]

decrease
in
fasting
↑Lactobacillus
glucose, LDS-cholesterol

[137]

decrease in pathological
24
severity
of
steatosis, ↓Clostridium
sp.
ID4,
tomato
[113]
weeks hepatic TG, TNF-α, IL-1β ↓Clostridium
and IL-6
(IL, interleukin; HOMA-IR, homeostatic model assessment for insulin resistance; TNF, tumor necrosis factor; MCP, monocyte
chemoattractant protein; NLRP, Nod-like receptor protein; TG, triglyceride; ZO-1, zonula occludens-1; LBP, LPS-binding protein;
NFkB, nuclear factor kappa-light-chain-enhancer of activated B cells; LDL, low-density lipoprotein; NAFLD, non-alcoholic fatty liver
disease.)
BCO1−/−/BCO2
−/−
double
knockout mice

Oral,
4.19 %
w/w
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2.3.2 Colonic Inflammation
In the host, homeostasis of gut microbiota is required to maintain health. When
the balance of bacterial community in the colon becomes disrupted, it may trigger
abnormal immune responses and induce colonic inflammation [138]. For example,
certain species of bacteria were considered the stimuli to the colonic inflammation, and
the increase in these bacteria, e.g. pathogenic E. coli, was strongly associated with
colonic inflammation [139]. On the other hand, several strains of Bifidobacterium and
Lactobacillus can produce anti-inflammatory effects by modulating the inflammation
related cell signaling pathways [140], and the ample presence of these bacteria in the gut
may protect the host against colonic inflammation. Colonic inflammation was associated
with the reduction of Firmicutes [141], Bacteroides [141], Bifidobacterium adolescentis
[142], Faecalibacterium prausnitzii [141], Lactobacillus and Eubacterium [143], and the
increase in Enterobacteriaceae and Ruminococcus gnavus [142, 144]. Studies have
supported the notion that whole fruits and vegetables inhibit colonic inflammation via
modulating related bacteria. Administration of whole cranberry powder or strawberry
powder in the diet of dextran sulfate sodium-treated mice for 6 weeks increased fecal
abundance of Lactobacillus and Bifidobacterium, which was associated with suppression
of colonic inflammation [145-147]. In a genetically induced colitis mouse model, dietary
consumption of blueberry or broccoli powder (10% w/w in diet) remarkably reduced the
abundance of Clostridium perfringens and Escherichia coli [148]. These bacteria were
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positively associated with colonic inflammation [139, 149]. The anti-inflammatory
potential of whole foods in the colon could stem from (i) the bioactive components in the
whole foods, (ii) altered gut microbiota induced by the whole foods, and/or (iii)
microbiota-derived metabolites of whole food components. For example, Anthocyaninrich fractions from red raspberry showed anti-inflammatory effects against LPS-induced
inflammation in macrophages, which was evidenced by the suppression of NO synthesis,
as well as the downregulation of iNOS, COX-2, IL-1β and IL-6 [150]. Probiotic
Bifidobacterium could suppress inflammation both in vitro and in vivo [151, 152].
Fermentation of MACs from whole foods by gut bacteria produces SCFAs, especially
butyrate, that showed anti-inflammatory effect through inhibition of NFB pathway and
regulation of T cell functions [153, 154]. It is noteworthy that these three modes of
actions often coexist in the colon and are likely to interact with each other, therefore,
produce modified health outcomes in comparison with that produced by each mode of
action alone. Recently, an increasing number of studies demonstrated the anti-colonic
inflammation effects of whole fruits and vegetables, such as cranberry, strawberry,
mushroom, and anthocyanins-containing potatoes [52, 145, 147, 155, 156]. However, the
detailed mechanistic understanding of how whole food components and gut microbiota
interact to produce inhibitory effects against colonic inflammation is lacking, therefore
warrants further investigation.
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Probiotics, such as Bifidobacteria and Saccharomyces, have been shown to offer
protective effects against colonic inflammation [152]. Moreover, probiotics supplemented
with food components might produce synergistic effects to confer benefits to the host.
For example, a synbiotic supplementation, which contained whole plant sugar cane fiber
and Bacillus coagulans, induced a stronger suppression on colonic inflammation than
either whole plant sugar cane or Bacillus coagulans alone [157]. Akkermansia, an
emerging probiotic has demonstrated anti-inflammatory effects in the colon via
stimulating mucin production and improving gut barrier [126, 158, 159]. Patients with
colonic inflammation showed a lower fecal abundance of Akkermansia [160]. Oral
administration of Akkermansia to dextran sulfate sodium-treated mice ameliorated
colonic inflammation, which was evidenced by the lower colon histological score and
reduced colonic levels of pro-inflammatory cytokines [161].

Although Akkermansia showed consistent protective effects against obesity and
diabetes, the role of Akkermansia in colonic inflammation remains controversy. For
example, higher abundance of Akkermansia has been found in patients with IBD and
colitic mice in comparison to the corresponding healthy counterparts [162-164]. An
possible explanation is that decreased thickness of mucus layer in the inflamed colon led
to the outgrowth of Akkermansia [165], consequently, the growth of Akkermansia in the
lumen is elevated due to its access to ample substrates in the stool [166]. In line with
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these findings, colitic mice had a high fecal abundance of Akkermansia than non-colitic
mice, and consumption of whole strawberry or cranberry inhibited the colonic
inflammation and decreased the fecal abundance of Akkermansia [145, 147]. It is possible
that the protective effects of whole berries against colonic inflammation maintained
integrity of the colonic tissue, which in turn prevented migration of Akkermansia from
mucus to the lumen [117]. A recent study showed that oral administration of Akkermansia
muciniphila induced colitis in germ-free IL10-/- mice by degrading mucus and producing
LPS in the colon [167]. This finding was opposite to that of another report, where oral
gavage of Akkermansia muciniphila inhibited colitis in mice [161]. Different cellular
components of Akkermansia were found to exert distinct functions in colon health. For
example, the outer membrane of Akkermansia was reported to induce inflammation by
upregulating the pro-inflammatory cytokines (IL-1β and IL-6) in bone-marrow-derived
macrophage [167], whereas, Amuc_1100 protein, isolated from outer membrane of
Akkermansia, was able to improve gut barrier in high fat-fed mice [127]. These findings
highlighted the complexity of gut microbiota and its role in host health.

36

CHAPTER 3

NON-EXTRACTABLE POLYPHENOLS FROM CRANBERRY: A POTENTIAL
ANTI-INFLAMMATION AND ANTI-COLON CANCER AGENT

3.1 Introduction

Polyphenols are a major class of dietary phytochemicals which are responsible for
many health benefits. Current research on dietary polyphenols mainly focus on a fraction
of polyphenols, known as extractable polyphenols (EP) [15, 16]. EP can be extracted
from food with aqueous-organic solvents (e.g. water, methanol, ethanol, acetone) [17,
18], and are often considered as “total phenolic content” for various biological studies.
However, another fraction of polyphenols remains in the residues after solvent extraction,
and they are known as non-extractable polyphenols (NEP) [16, 19]. NEP are mainly
polyphenols that bound to dietary fiber or other macromolecules through hydrophobic
interaction, hydrogen bonding and covalent bonding [15, 16]. NEP is not significantly
released from the food matrix during digestion in the stomach or small intestine, therefor
they reach colon nearly intact [20]. In the colon, NEP may be released from food matrix
by the action of microbiota and become bioavailable and bioactive. In contrast, EP tend
to be absorbed and metabolized in the upper gastrointestinal tract, therefore, their
biological fate is quite different from that of NEP. Only unabsorbed EP and their

37

metabolites could reach the colon. The better colonic bioavailability of NEP than EP
makes NEP promising candidates for promoting colon health.

Colon diseases such as inflammatory bowel diseases (ulcerative colitis and
Crohn’s disease) and colon cancer have posed serious threats to the human health. Colon
cancer is one of the leading causes of death in both of male and female in the United
States, and colitis is a key risk factor for colon carcinogenesis [168, 169]. The prevention
of colon cancer is the most logical method to controlling it, which is suggested by
accumulating evidence [170, 171]. Berries and their components have been subject of
many studies for the anti-inflammatory and anticancer effects. Cell culture studies have
demonstrated the inhibitory effects on human colon cancer cells by the extracts of various
berries such as blackberry, black raspberry, red raspberry, blueberry, cowberry [17].
Berries (e.g. chokeberry, red raspberry, strawberry, cowberry) and their extracts have
been shown to have anti-inflammatory and anticancer effects in the intestine of various
animal models such as AOM-induced rat colon cancer model, Apc 1638+/- mouse and
Muc2-/- mouse model, and DSS-induced colitis models [12, 14, 156].

Cranberry is a native berry fruit of North America, and it is abundant of
polyphenols including flavan 3-ols, proanthocyanidins, anthocyanins and phenolic acids
[21]. Majority of studies on cranberry have been focused on its antibacterial actions [22].
To date, the inhibitory effects of cranberry on colonic inflammation and colon cancer
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have not been adequately studied. Cranberry extracts have been shown to inhibit colon
cancer cell growth and suppress pro-inflammatory enzymes expression [21]. However,
most published studies focused on EP of cranberry, and NEP has been neglected. The
object of this study is to characterize EP and NEP fractions from cranberry and determine
their potential in anti-inflammation and anti-colon cancer.

3.2 Materials and methods

3.2.1 Materials

Cranberry (Early Black variety) was harvested at State Bog, Wareham, MA
(September 2011), and whole cranberry powder was obtained by freeze-drying from fresh
cranberry fruits. The freeze-dried whole cranberry powder is deep red in color and freeflowing. procyanidin B2, procyanidin A2, cyanidin 3-arabinoside, peonidin 3-glucoside
were from Shyuanye (Shanghai, China). Myricetrin, astragalin, myricetin, quercetin, ρcoumaric acid, ferulic acid, protocatechuic acid, chlorogenic acid, caffeic acid, and benzoic
acid were from Quality Phytochmicals, LLC (Ease Brunswick, NJ).

3.2.2 Extraction of EP

100g freeze-dried cranberry powder was mixed with 70% (v/v) acetone aqueous
(1% acetic acid). The mixture was sonicated for 30 min at room temperature, and the
supernatant was collected after centrifuging at 4000 g for 5 min. The residues were
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extracted twice more, pooled the supernatants. The supernatant was concentrated and
then dissolved in methanol. Hexane was used to remove fat and other highly lipophilic
molecules in extracts, after which the supernatant was concentrated at 40 ℃ to dryness.
EP fraction was collected and stored in -20 ℃ for further studies.

3.2.3 Extraction of NEP

The residues obtained after EP fractionation were treated with 2 M NaOH at
37 ℃ for 2 h after purging container with nitrogen to protect polyphenols from oxidation.
After alkaline hydrolysis, mixture was adjusted to pH 2 with 6 M HCl, centrifuged at
4000 g for 10 min to obtain supernatant. The supernatant was extracted by ethyl acetate
and diethyl ether (1:1, v/v) for three times. The Pooled supernatants were concentrated to
dryness under vacuum. The NEP fraction was collected and stored in -20 ℃ for further
studies.

3.2.4 Determination of total phenolic contents (TPC), flavonoid contents (FC), tannin
contents (TC), and ORAC

TPC was measured using the Folin-Ciocalteu method with some modifications
[172]. Sample was dissolved in 50% methanol at the final concentration 0.4 mg/mL.
Twenty µL Folin-Ciocalteu reagent was added to a 96-well plate containing 20 µL sample
and 20 µL distilled water. The plate was tapped gently on all sides and kept at room
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temperature for 10 min, followed by addition of 140 µL 7% sodium carbonate. After 90
min at room temperature, the absorbance was measured at 760 nm (BioTek Instrument,
Inc. Vermont, VT, USA). Results are expressed as microgram of gallic acid equivalents
per gram.

FC was determined as previously described with some modifications [173].
Briefly, 20 µL 0.4 mg/mL sample was mixed with 100 µL distilled water and 10 µL 5%
sodium nitrite in a 96-well plate. After 6 min, 20 µL 10% aluminum chloride was added
in the mixture and allowed to react for 5 min. Subsequently, 50 µL 1 M sodium
hydroxide was added in the mixture. Tap the plate gently on all sides for 2 min, and the
absorbance was read at 510 nm (BioTek Instrument, Inc. Vermont, VT, USA). The results
are expressed as microgram of catechin equivalents per gram.

TC was tested as previously described with modifications [174]. The vanillinH2SO4 solution was made of 4% vanillin in methanol and 30% H2SO4 in methanol in the
ratio of 1:1. One hundred eighty µL vanillin-H2SO4 solution was added in a 96-well plate
containing 20 µL 0.4 mg/mL sample. The absorbance was determined at 510 nm (BioTek
Instrument, Inc. Vermont, VT, USA), and results are expressed as microgram of catechin
equivalents per gram.

The antioxidant capacity was determined by ORAC assay following the
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previously published method with modifications using microplate reader (BioTek
Instrument, Inc. Vermont, VT, USA) [175].

3.2.5 LC-MS analysis

Identification and quantification of selected flavonols, flavanols, anthocyanins
and phenolic acids were carried out by LC-MS as described preciously with some
modification [176]. Chromatographic separation of anthocyanins was carried out on
Zorbax SB-Aq C18 column (150 mm ×4.6 mm, 5μm, Agilent Technologies, USA).
Separation of flavonols, flavan 3-ols and phenolic acids were achieved on Kinetex XBC18 column (100 mm ×4.6 mm, 2.6 μm, Phenomenex, Torrance, CA, USA). The mobile
phase consisted of 0.1% formic acid in 95% water mixed with 5% ACN (solvent A), and
0.1% formic acid in ACN (solvent B). The elution program processed as follows: 0-2
min, isocratic elution with 5% B; 2-37 min, 5-95% B; 37-40 min, 95-100% B; 40-46 min,
100-5% B; 46-52 min, isocratic elution with 5% B. The flow rate was 0.4 mL/min, and
injection volume was 10 µL. Proanthocyanidins B2, proanthocyanidins A2, ECG,
myricetrin, astragalin, myricetin, p-coumaric acid, ferulic acid, protocatechuic acid,
chlorogenic acid, caffeic acid, benzoic acid, cyanidin 3-arabinoside, peonidin 3-glucoside
were used as external standards.

42

3.2.6 Determination of cell viability, colony formation, cell cycle and apoptosis

Assays for cell viability, colony formation, cell cycle and apoptosis were
performed as we previously described [177-180]. In brief, HCT116 cells were purchased
from the American Type Culture Collection (ATCC, Rockville, MD, USA). HCT116
(2,500 cells/well) were cultured in RPMI-1640 media supplemented with 5% heatinactivated FBS, 100 units/mL of penicillin, and 0.1 mg/mL of streptomycin (Mediatech,
Herndon, VA) at 37 ℃ with 5% CO2 and 95% relative water humidity. After 24 hours of
attachment, cells were treated with serial concentrations of EP and NEP for 24 h, then cell
viability was determined by MTT assay [177].

HCT116 (400 cells/well) were seeded in 6-well plates. After 24 hours attachment,
cells were subjected to the treatment of serial concentration of EP and NEP. The media in
6-well plate were refreshed every 2 days. After 14 days, the determination of colony
formation was conducted as we described previously [180].

HCT116 (4 × 104 cells/well) were seeded in 6-well plates for cell cycle and
apoptosis analysis. After 24 hours of incubation and attachment, cells were treated with 16
µg (GAE)/mL NEP for 24 h, and then cells were collected by brief trypsinization (0.25%
trypsin-EDTA; Mediatech)for analysis by flow cytometry to determine cell cycle or
apoptosis [177, 180].
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3.2.7 Nitric oxide assay and immunoblotting

RAW 264.7 were purchased from the American Type Culture Collection (ATCC,
Rockville, MD, USA). RAW 264.7 cells were cultured in RPMI-1640 media
supplemented with 10% heat-inactivated FBS (Medistech, Herndon, VA, USA), 100
units/mL of penicillin, and 0.1 mg/mL of streptomycin (Sigma-Aldrich, St. Louis, MO,
USA) at 37 ℃ with 5% CO2 and 95% air. Griess reaction was used to determine the
concentration of nitrite in the culture media, which is an indicator of NO production
[181]. RAW264.7 cells (5 × 105) were seeded in 96-well plates. After 24 hours, cells were
treated with different concentrations of EP or NEP for 24 hours. After 24 hours treatment,
the media were mixed with an equal volume of Griess reagent mixture (reagent A: 1%
sulfanilamide in 5% phosphoric acid, reagent B: 0.1% naphthylethylenediamine
dihydrocholoride aqueous). Then the production of NO was determined at 540nm with a
plate reader.

Whole cell lysate from macrophages was extracted as we reported previously [177179, 182]. Briefly, RAW 264.7 cells (2.5 × 105 cells/mL) were cultured in cell culture dishes.
After 24 h attachment, the media were replaced by 1µg/mL lipopolysaccharides (LPS) with
or without serial concentration of NEP. After 24 h, cell lysate was collected and subject to
western blot analysis as we did previously [182].
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3.2.8 Data Analysis

All results were presented as mean ±SD. Analysis of variance (ANOVA) was used
to compare the differences among two or more groups. ρ< 0.05 was considered to be
statistical significance.

3.3 RESULTS AND DISCUSSION

3.3.1 EP and NEP in cranberry

Acetone and acetone aqueous are commonly used to extract polyphenols from fruits
and vegetables. It was reported that acidic acetone was more effective in extracting
polyphenols such as anthocyanins, flavan-3-ols and phenolic acids, than other solvents [18].
In order to increase the extraction rate of phenolic conjugates (e.g. β-glycosides), 70%
acetone aqueous with 1% acetic acid was used to extract EP from cranberry (the yoeld of
EP is 25,610 mg/100g dry powder) [183]. Alkaline hydrolysis was used to release NEP
because it could release more NEP from plant matrix than acid hydrolysis or enzyme
hydrolysis (the yield of NEP is 3,559.5 mg/100g dry powder) [184]. TPC, FC and TC of
EP and NEP were shown in Figure 2. In general, EP had higher TPC, FC and TC than NEP.
NEP content of cereals was found to be higher than that of EP [19, 185], while fruits had
higher contents of EP than NEP [186]. The relative abundance of NEP vs. EP in cranberry
was in consistence with the findings of previous studies about NEP from different fruits
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including apple, orange, banana and grape [16, 187]. Both EP and NEP were more abundant

d e r

3 0 0 0

p o w

2 5 0 0

/ 1 0 0 g

2 0 0 0

E

in tannins than flavonoids (Figure 2).

1 5 0 0

*

*
E

P

N

E

P

1 0 0 0

E

o r

C

* *

A

*

m

g / G

5 0 0

0

C

C

C

P

F

T

T

*

*

1 4 0 0

1 2 0 0

1 0 0 0

8 0 0

6 0 0

( 

m

o l

T

E

/ g

e x t r a c t )

Figure. 2 Total phenolic content (TPC), flavonoid content (FC), and tannin content (TC)
of EP and NEP fractions of cranberry. (GAE: gallic acid equivalents; CE: (+)-catechin
equivalents). Data represent mean ± SD (n=3), * indicates p<0.05, ** indicates p<0.01.
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Figure. 3 Oxygen radical absorbance capacity (ORAC) of EP and NEP (TE: Trolox
equivalents). Data represent mean ± SD (n=6), ** indicates p<0.01.
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3.3.2 Chemical profiles of EP and NEP
The chemical profiles of EP and NEP were determined by HPLC-MS, results
were presented in Table 3. Majority of the phenolic compounds identified by comparing
their retention times and fragmentation patterns with those of standards occurred in both
EP and NEP, for example procyanidin A2, myricitrin, astragalin, p-coumaric acid,
protocatechuic acid, chlorogenic acid and benzoic acid. In EP fraction, the main
constituents were anthocyanins, including cyanidin-3-arabinoside and peonidin-3glucoside, whereas anthocyanins were not found in NEP fraction. The major components
in NEP were phenolic acids, including chlorogenic acid, p-coumaric acid, ferulic acid,
caffeic acid, protocatechuic acid and benzoic acid, and the total content of phenolic acids
was more than 10 times higher than that of EP. Meanwhile, all the phenolic acids
described above were found in NEP of cranberry for the first time, although some of
them have been previously found in EP fraction of cranberry [188]. Previous studies
reported that cranberry was abundant of proanthocyanidins that contributed to various
health benefits, especially those with unusual A-type linkages [189, 190]. Importantly,
proanthocyanidins were also found in NEP fraction, and their abundance was higher than
that in EP. Although the major polyphenols in NEP were phenolic acids, other kinds of
flavonoids were also found in NEP, such as myricitrin, myricetin, and astragalin.
Although alkaline hydrolysis has been frequently used to release phenolics from fiber, it
also can break the esters and glycoside linkages of phenolic components after the release,
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which is a factor to be considered when interpreting the chemical profiles of NEP
fraction. Proanthocyanidins or condensed tannins have been reported in EP from
cranberry [191]. Interestingly, our results showed the existence of tannins in cranberry
NEP and their abundance was much higher than EP, especially procyanidin A2 as shown
in Table 3.

3.3.3 Antioxidant capacity of EP and NEP

ORAC was used to determine the antioxidant capacity of EP and NEP. EP and
NEP showed ORAC values of 984.17 μmol TE/g(extract) and 1258.53 μmol
TE/g(extract), respectively (Fig.3). The abundance of anthocyanins, flavanols, flavonols
and phenolic acids in EP fraction might contribute to the antioxidant capacity, especially
anthocyanins (e.g., cyanidin 3-arabinoside and peonidin 3-glucoside) which have been
reported for their antioxidant capacity (Table 3) [192]. Notably, phenolic acids were the
dominant phenolic constituents in NEP (Table 3), and they may responsible for the
antioxidant capacity of NEP [193]. Importantly, the major compounds reported in urine
after the consumption of berries were phenolic acids [81, 194], increasing numbers of
studies have been focused on the phenolic acids produced from the metabolism of food
components and their contribution to the human health.
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Table 3 Phenolic Compounds Identified by LC-MS in EP and NEP from cranberry.
compound

Retention
Time

MS (m/z)

NEP (mg/g extract)

EP (mg/g extract)

procyanidin B2

8.99

579[M+H]＋

N

0.09 ± 0.02

10.15

577[M+H]＋

1.12 ± 0.23

0.40 ± 0.00

9.98

443[M+H]＋

0.18 ± 0.06

0.13 ± 0.00

9.60

463[M+H]＋

1.09 ± 0.20

0.81 ± 0.02

10.10

447[M+H]＋

0.58 ± 0.12

0.20 ± 0.01

11.50

319[M+H]＋

0.15 ± 0.02

N

quercetin
total flavonols and flavanols

22.72

303[M+H]＋

0.16 ± 0.01
3.28

0.18 ± 0.06
1.81

cyanidin 3-arabinoside

26.01

420[M+H]＋

N

1.79 ± 0.07

30.86

450[M+H]＋

N

2.10 ± 0.04

22.99

464[M+H]＋

N

5.43 ± 0.12

peonidin 3-glucoside
total anthocyanins

26.74

464[M+H]＋

N

1.95 ± 0.18
11.27

p-coumaric acid

27.02

165[M+H]＋

4.52 ± 0.11

0.31 ± 0.12

27.30

195[M+H]＋

0.33 ± 0.01

N

0.46 ± 0.02

0.16 ± 0.04

procyanidin A2
ECG
myricetrin
astragalin
myricetin

cyanidin 3-galactoside
peonidin 3-galactoside

ferulic acid

-

protocatechuic acid

21.20

chlorogenic acid

21.53

153[M-H]
355[M+H]＋

10.54 ± 0.29

0.33 ± 0.13

24.30

181[M+H]＋

0.37 ± 0.04

N

7.16

123[M+H]＋

0.10 ± 0.03
16.31

0.66 ± 0.11
1.46

caffeic acid
benzoic acid
total phenolic acids

3.3.4 Anti-inflammatory effects of EP and NEP in RAW264.7 macrophages

To determine the anti-inflammatory effects of EP and NEP, their effects on the
growth of RAW264.7 macrophages were firstly determined by cell viability assay.
Neither EP nor NEP showed cellular toxicity at the concentration range of 2 -16 µg gallic
acid equivalent (GAE)/mL (data not shown). After establishing the nontoxic
concentration range, the effects of EP and NEP on nitric oxide (NO) production induced
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by LPS (1µg/mL) in macrophages were determined. NO is an important inflammation
mediator whose production can be induced by LPS. As shown in Figure 4, at 4 and 8 µg
GAE/mL, EP treatment showed 15% inhibition of the production of NO in comparison
with the LPS-treated positive control group. Although NEP caused similar suppression as
EP on NO production at 4 µg GAE/mL, NEP markedly lowered the production of NO by
32% at 8 µg GAE/mL, when compared to the positive control group. At 16 µg GAE/mL,
NEP caused 53% inhibition on NO production, while EP at the same concentration
inhibited the production of NO by only 12%, when compared to the positive control. The
difference between EP and NEP in terms of the suppression of NO production is expected
to be due to their different chemical profiles. For example, higher levels of phenolic acids
including chlorogenic and p-coumaric acids in NEP may contribute to the higher antiinflammatory effects of NEP in comparison with EP [195, 196].
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Figure. 4 Effects of EP and NEP on LPS-induced nitric oxide production in RAW 264.7
macrophages. The cells were treated with or without 1 µg/mL LPS or LPS plus different
concentrations of EP and NEP fractions for 24 hours. Then the media was collected and
determined the NO production as described in Materials and Methods. Results were
expressed as mean ± SD (n=6). *p< 0.05 and **p<0.01 indicate statistical significance,
when compared to LPS treatment group.
Since NEP had much stronger inhibitory effects than EP on NO production in
RAW 264.7 macrophages, we further investigated molecular mechanism by which NEP
inhibited NO production. Inducible nitric oxide synthase (iNOS) is one of the important
pro-inflammatory proteins [182]. The expression of iNOS was very low without LPS
treatment, while LPS treatment significantly increased iNOS expression by 22.7-fold
(Figure 5A). NEP showed a dose dependent inhibition on the expression of iNOS, and
NEP at 8 and 12 µg GAE/mL significantly suppressed expression levels of iNOS by 68%
and 84%, respectively (Figure 4A). We examined expression levels of nuclear p50 and pIκBα, both of which play critical role in the mediation of inflammation. p50 is the
functional subunit of NF-κB pathway, and phosphorylation of IκBα results in dissociation
of IκBα from NF-κB, and activated NF-κB initiates pro-inflammatory responses [182].
The results demonstrated a dose dependent inhibition on the expression of nuclear p50 by
NEP, and especially, NEP at 8 and 12 µg GAE/mL decreased the levels of nuclear p50 by
more than 80% when compared to that of LPS-stimulated positive control cells (Figure
5B). Also, expression levels of p-IκBα were suppressed by NEP treatment at 8 and 12 µg
GAE/mL. We further determined the effects of NEP on the expression levels of HO-1, an
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antioxidant enzyme, which involves in the inflammation. HO-1 expression contributes to
the adaptive increase of cellular anti-oxidant capacity, and it is important targets for antiinflammation remedy [181]. Results indicated that NEP treatment caused a dosedependent increase in the expression of HO-1, especially, at 8 and 12 µg GAE/mL NEP
increased HO-1 expression by 4.2-fold and 6.7-fold compared to the LPS-treated positive
control cells, respectively (Figure 5C). The expression levels of Nrf2, a transcription
factor of HO-1 gene, which involves in the induction of HO-1, was significantly
increased by NEP treatment at 8 and 12 µg GAE/mL.
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Figure. 5 Inhibitory effects of NEP on LPS-induced proteins expression of iNOS (A), p50, p-IκBα (B), HO-1 and Nrf2 (C) in RAW 264.7 macrophages. RAW 264.7 cells were
seeded in culture plates for 24 h, and then treated with different concentrations of
NEP.After 24 h, cells were collected for Western blotting analysis. The numbers
underneath the blots represent band intensity that was normalized by β-actin (cytosolic
fraction) or PARP (nuclear fraction). *p<0.05 and **p<0.01 indicate statistical
significance in comparison with LPS-treated group (n=3). The standard deviations (all
within ±15% of the means) were not shown.
3.3.5 Anti-colon cancer effects of EP and NEP on human colon cancer cells

Accumulating studies suggest that various polyphenols derived from fruits and
vegetables possess anticancer effects in various models. As a rich resource of
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polyphenols, EP and NEP from cranberry potentially also have anticancer capacity. NEP
cannot be released from the food matrix in the stomach or small intestine, they reach
colon nearly intact [20], where they may show biological benefits after being released
from matrix by gut microbiota-mediated fermentation. Therefore, we determined the anticolon cancer potential of cranberry EP and NEP. Cell viability assay revealed that both
EP and NEP showed inhibition on the growth of cancer cells. NEP had stronger
inhibitory effects on the growth of human colon cancer HCT116 cells than EP at the
concentration range of 2-16 µg GAE/mL, and NEP treatment showed a dose-dependent
inhibition (Figure 6A). At the concentration of 16 µg GAE/mL, NEP and EP caused
inhibition on cell viability by 20% and 60%, respectively. In consistence with the cell
viability assay, colony formation assay indicated that EP and NEP showed suppression
on the colony formation of colon cancer cell. And NEP had stronger inhibitory effects on
colony formation of colon cancer cells, for example, at 6 µg GAE/mL, NEP and EP
inhibited the colony formation of HCT116 cells by 64% and 35%, respectively (Figure
6B).
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Figure. 6 (A) Inhibitory effects of EP and NEP fractions on the viability of HCT116
human colon cancer cells in MTT assay. HCT116 cells (2500 cells/well) were seeded in
96-well plates for 24 h, and then treated with serial concentrations of EP and NEP. After
24 h, cells were subjected to MTT assay. Data represent mean ± SD (n=6). (B) Inhibitory
effects of NEP and EP fractions on the colony formation capacity of HCT116 cells.
HCT116 (400 cells/well) were seeded in 6-well plates. After 24 hours, cells were
subjected to the treatment of different concentrations of EP and NEP. The media in 6-well
plate were refreshed every 2 days. After 14 days, the determination of colony formation
was conducted. Data represent mean ± SD (n=3). (C)Images of colony formation
ofHCT116 cells under different treatments. *p<0.05 and **p<0.01 indicate statistical
significance in comparison with control group.
Since NEP showed stronger inhibitory effects on the growth of the colon cancer
cells in comparison with EP, we further investigated the mechanism by which NEP
inhibit the colon cancer cell viability and colony formation. We determined the effects of
NEP on cell cycle progression and cellular apoptosis of HCT116 cancer cells by flow
cytometry as we described previously [180]. Based on results obtained from cell viability
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and colony formation assay, we selected a NEP dose of 16 µg GAE/mL to determine its
effects on cell cycle progression and apoptosis. The results revealed that NEP-treatment
significantly increased the cell population in G0/G1 phase and decreased the cell
population in S phase in comparison with the control, suggesting a cell cycle arrest at the
G0/G1 phase (Figure 7A). After treatment with NEP, early and late apoptotic cell
populations were increased by 3.8-fold and 6-fold, respectively, compared to the control
group (Figure 7B).

Figure. 7 Effects of NEP fraction from cranberry on cell cycle progression (A) and
apoptosis (B) of HCT116 human colon cancer cells. HCT116 were seeded in 6-well
plates for 24 h, then treated with or without 16 µg GAE/mL NEP. After 24 h treatment,
cells were collected and subjected to cell cycle or apoptosis analysis with help of flow
cytometry as described in Materials and Methods. * p<0.05 and **p<0.01 represent
statistical significance in comparison with control group (n=6).
In summary, this study provided an understanding of EP and NEP from cranberry
in terms of their chemical properties and biological functions. Chemical profile of
cranberry NEP was firstly determined, which showed that NEP possessed higher contents
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of phenolic acids than EP. Meanwhile, NEP showed higher anti-oxidant capacity than EP
(Fig.2). EP fraction in fruits have been extensively studied, such as their anti-oxidant,
anti-inflammatory, anti-cancer, and antibacterial effects. However, reports about NEP
have been scarce. NEP could bind to fiber and they may reach colon intact [15], so that
the biological effects of NEP have been considered important for colon health. Our
results indicated that both EP and NEP from cranberry had various biological effects.
Importantly, NEP showed the promising anti-inflammatory and anti-cancer capacities.
The high bioavailability of NEP in the colon facilitate the realization of these activities in
the colnic tissues. Moreover, the potential interaction between gut microbiota and NEP
could also play an important role in colon health. NEP could be biotransformed by gut
microbiota to produce bioactive metabolites that may contribute to the promotion of
colon health as well [197]. Therefore, it is important to investigate the interaction of gut
microbiota and NEP in the colon in terms of production of bioactive metabolites.
Meanwhile, composition and functions of gut microbiota can be altered by the presence
of polyphenols in the colon, which in turn could affect colon health [198]. Unfortunately,
the mode of interplay between NEP and gut microbiota in the colon is largely unknown,
and much more efforts are needed to explore this promising research area. The
knowledge obtained from our study is helpful for a better understanding of polyphenols
in berries, especially the potential biological effects of NEP in the colon. Overall, this
study provided the first line of evidence to support the notion that NEP could be a
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promising beneficial agent for colon health. Certainly, further investigation is warranted
to elucidate the detailed model of actions of NEP in the colon, especially in relationship
with gut microbiota.
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CHAPTER 4

NON-EXTRACTABLE PHENOLICS FROM STRAWBERRY: ANTIINFLAMMATION AND ANTICANCER POTENTIALS

4.1. Introduction
Strawberry is an important source of polyphenolic compounds, especially
phenolic acids such as ferulic, p-coumaric, vanillic, caffeic, syringic, and sinapic acids
and flavonoids [199]. Thus, strawberry has been popularly produced and consumed
because of both as its delicious taste and health beneficial properties. Phenolics are
important contributors to the diverse health benefits of strawberry including antiinflammation [200], anti-cancer [201], antioxidants and anti-diabetes [202]. In nature,
phenolic compounds generally exist in the free and bound forms in plant cells. The free
phenolic compounds are solvent extractable phenolics (EP). In contrast, the nonextractable phenolic compounds (NEP), which are covalently bound to the plant matrix,
cannot be extracted into water or aqueous/organic solvents mixtures [203]. NEPs are high
molecular weight polymeric polyphenols or individual low molecular weight phenolics
mainly cross-linking with macromolecules, such as polysaccharides, dietary fiber and
proteins. They can be retained in the food matrix inaccessible to solvents due to different
interactions with the plant matrix [204]. It is noteworthy that most of phenolics in
strawberry are NEP [15]. The total phenolic compounds with anti-inflammation [200] and
anti-cancer [201] property of strawberry have been reported, which lots of bibliographic
information mainly involves the biological activities of EP present in the berries [205].

59

Scarce information of NEPs on potential biological activities such as anti-inflammatory
and anti-cancer are available [206, 207]. Although NEP is not available for extraction and
absorption, they can be released under the low pH conditions of the gastrointestinal tract
and upon colonic fermentation [208, 209]. Upon release, they can be absorbed in the gut
lumen and exert a biological effect. Therefore, characterization of NEP and their antiinflammation and anti-cancer activity is of paramount importance to the understanding of
the health benefits of strawberries.
Colorectal cancer is the third most common cancer diagnosed in both men and
women, and is one of the leading causes of death in the United States and worldwide
[210]. Inflammatory bowel diseases play a key role in colon carcinogenesis.
Consumption of fruits, vegetables and their bioactive constituents has been recommended
to prevent colon cancer development. The health benefits of fruits and vegetables on
reducing cancer risk are at least in part associated with the presence of unique
polyphenolic compounds.
In this study, we firstly aimed to determine the potential anti-inflammatory effects
of NEP in LPS-stimulated RAW 264.7 cells, and the underlying mechanisms of action.
Secondly, we sought to investigate the inhibitory activity of NEP in HCT-116 colon
cancer cells, and its effects on cell cycle progression and apoptosis.
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4.2. Material and methods

4.2.1 Materials and Chemicals

Strawberry powder was obtained from Ocean Spray, Inc. (Lakeville, MA, USA).
Standards of phenolics such as ferulic acid, protocatechuic acid, chlorogenic acid, caffeic
acid, benzoic acid,myricetrin, astragalin, myricetin and p-coumaric acid were purchased
from Quality Phytochmicals, LLC (Ease Brunswick, NJ, USA). Antibody for β-actin,
HO-1, iNOS and c-FOS were purchased from Cell Signaling Technology (Beverly, MA,
USA). 3-(4, 5-dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium bromide (MTT),
propidium iodine (PI) and were purchased from Sigma-Aldrich (Natick, MA, USA).
Annexing V/PI double staining was obtained from Bio vision (Mountain View, CA,
USA). All chemical reagents used were of analytical grade.

4.2.2 Extraction of NEP

An ultrasonic-assisted extraction procedure was used for NEP [211]. Lyophilized
strawberry powder (100 g) was mixed with 700 mL of 70% (v/v) acetone and then placed
in an ultrasonic bath (300 Ultrasonik, Whittemore Enterprises, Inc., RanchoCucamonga,
CA, USA) and sonicated at the maximum power for 30 min under refluxing conditions.
After centrifugation of the resulting slurry for 5 min at 4000g (IEC Centra MP4,
International Equipment Co., Needham Heights, MA, USA), the supernatant was
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removed. Afterwards, the residues were subjected to extract NEP immediately [199].
Residues were hydrolyzed with 2M sodium hydroxide (NaOH) at 37 oC for 2 h with
stirring under nitrogen to protect phenolics from oxidation. The resulting slurry was
acidified to pH 2 with 6M HCl and extracted three times with diethyl ether and ethyl
acetate (1:1, v/v). Subsequently, supernatants were evaporated in vacuo at 4 oC (Buchi,
Flawil, Switzerland), lyophilized for 72 h at -46 oC (Freezone, model 77530, Labconco
Co., Kansas City, MO, USA) and stored at -20 oC until further analysis. During all stages,
extracts were protected from light by covering them with aluminum foil.

4.2.3 Determination of total phenolic content (TPC), flavonoid content (FC), tannin
content (TC)

TPC of strawberry extracts were determined using the Folin-Ciocalteu assay with
some modifications [212]. Briefly, sample was dissolved in 50% methanol to final
concentration 0.4 mg/mL. 20 µL of Folin-Ciocalteu reagents were added in 96-well plate
containing 20 µL of sample and 20 µL of distilled water. After incubation at room
temperature for 10 min, 140 µL of 7% sodium carbonate was added. The reaction was
incubated at room temperature for 90 min, followed by absorbance measurement at 760
nm using a spectrophotometer (BioTek Instrument, Inc. Winooski, VT, USA). Gallic acid
was used as a standard, and TPC were expressed in milligram gallic acid equivalent (mg
GAE/100g strawberry powder).
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FC were determined by the aluminum colorimetric method and the catechin was
used as standard [212]. 20 µL of 0.4 mg/mL sample was mixed with 100 µL distilled
water and 10 µL of 5% sodium nitrite in 96-well plate. After 6-min incubation at room
temperature, 20 µL of 10% aluminum chloride was added in the mixture and allowed to
react for 5 min. Subsequently, 50 µL of 1 M NaOH was added in the mixture. After
incubation at room temperature for 2 min, the absorbance was read at 510 nm using a
spectrophotometer (BioTek Instrument, Inc.). The results are expressed as milligram of
catechin equivalents per /100g strawberry powder (mg CE/100g powder).

TC was tested according to the method described by Jackson with slight
modifications [213]. Vanillin- H2SO4 solution was prepared by the ratio of 4% vanillin in
methanol to 30% H2SO4 in methanol of 1:1. 180 µL of vanillin-H2SO4 solution was
mixed with 20 µL of 0.4 mg/mL sample in 96-well plate. The absorbance was measured
at 510 nm using a spectrophotometer (BioTek Instrument, Inc.), and results are expressed
as milligram of catechin equivalents (mg CE/100g strawberry powder).

4.2.4 Phenolics composition analysis

Identification and quantification of flavonols, flavanols and phenolic acids were
carried out by LC-MS as described preciously with some modification [214]. Separation
of flavonols, flavan 3-ols and phenolic acids were achieved on Kinetex XB-C18 column
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(100 mm ×4.6 mm, 2.6 μm, Phenomenex, Torrance, CA, USA). The mobile phase
consisted of 0.1% formic acid in 95% water mixed with 5% acetonitrile (solvent A), and
0.1% formic acid in acetonitrile (solvent B). The elution program processed as follows:
5% B for 2 min, changed to 95% in 35 min, raised up to100% in 5 min, decreased to 5%
B in 6min, kept 5% B in 6 min, the overall analysis time was 52 min. The flow rate was
0.4 mL/min, and injection volume was 10 µL. ECG, myricetrin, astragalin, myricetin, pcoumaric acid, ferulic acid, protocatechuic acid, chlorogenic acid, caffeic acid and
benzoic acid were used as external standards, and limonin was used as internal standard.

4.2.5 Cell viability, colony formation, cell cycle and apoptosis
Cell viability, colony formation, cell cycle and cellular apoptosis were performed
as our previously published method [215-218]. In brief, HCT-116 (2500 cells/well) and
macrophages (AML-12, CCD-18, 12500 cells/well) were seeded in 96-well plates,
respectively. Serum-starved cells were treated with serial concentrations of NEP for 24 h,
then cell viability was determined by MTT method [216]. For colony formation analysis,
HCT-116 was plated in 6-well plate at a density of 400 cells/well. After 24 hours, cells
were treated with serial concentration of NEP. The medium in 6-well plate was refreshed
every 2 days. After incubation for 14 days, the determination of colony formation was
conducted as previously reported [217].

For cell cycle analysis, HCT-116 was seeded in 6-well plates. After 24 hours of
incubation, cells were treated with 20µg GAE/mL NEP. Cells were incubated for 24h and
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subjected to analyze using flow cytometry with propidium iodide (PI) staining [218]. For
apoptosis analysis, HCT-116 was treated with serial concentrations of NEP after seeded
in 6-well plates. Then cells were incubated for 48 h and collected for analysis by flow
cytometry [215].

4.2.6 Nitric Oxide (NO) assay

LPS-induced NO production was conducted according to the method of used in
our previous publication [219]. After 24 hours of RAW 264.7 cells seeding in 96 well
plate (at the concentration of 50 ×104 cells/mL with 200 µL in each well), cells were
treated with LPS (1µg/mL) together with testing compound for 24 hours followed by
relatively measurement of nitrite concentration which is an indicator and a more stable
product of NO. Briefly, 150µL of cell culture medium was mixed with 100µL of cold
Griess reagent (2% sulfanilamide and 0.2% N-(1-naphthyl) ethylenediamine
dihydrochloride in phosphoric acid), the mixture was incubated at room temperature for
30 minutes, and the absorbance at 540 nm was measured in a microplate reader. Cell-free
solution was used as a blank in every experiment. Percentage of nitric oxide inhibition
was then relatively determined.

4.2.7 Immunoblotting

Whole cell lysate from macrophages was extracted and analyzed as previously
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reported [217]. Briefly, RAW 264.7 cells were seeded in 10-cm culture dishes and
incubated for 24 h to attach on dishes. Then, the fresh medium containing 1mg/mL LPS
was replaced with or without serial concentrations of NEP. After 24 h, cell lysate was
collected and subjected to western blot analysis as previously mentioned.

4.2.8 Data Analysis

All results were presented as mean ±SD for the indicated number of
independently performed experiments. Student’s t-test and analysis of variance (ANOVA)
were used to compare the differences among two or more groups, respectively. p< 0.05
was considered statistically significantly difference.
Table 4. Phenolic profiles of NEP of strawberry fractions identified by HPLC-MS.
Retention
Time(min)

M± (m/z)

NEP
(mg/g extract)

flavonols and flavanols
ECG
EGCG

9.98
9.30

443+
459+

0.310 ± 0.120
0.140 ± 0.110

catechin

22.25

290+

0.087 ± 0.008

myricetrin
9.60
463+
0.074 ± 0.020
+
astragalin
10.10
447
3.500 ± 0.190
myricetin
11.50
319+
0.077 ± 0.013
phenolic acids
p-coumaric acid
27.02
165+
23.560 ± 4.40
ferulic acid
27.30
195+
1.600 ± 0.420
protocatechuic acid
21.20
153
0.890 ± 0.180
+
caffeic acid
24.30
181
5.100 ± 0.610
+
benzoic acid
7.16
123
0.840 ± 0.250
MS analysis was performed in positive and negative mode. Results are indicated as mean
± SD.
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4.3 Results and discussion

4.3.1 Phenolic profiles of NEP

Regarding linkage and polymerization of NEP with protein and fiber, acidolytic
method may partially release NEP. Thus, alkaline hydrolysis was conducted to release
NEP by depolymerization and solubilization of cell walls [220, 221]. Figure 8 shows the
total phenolic (TPC), flavonoids (FC) and tannin content (TC) of NEP fraction from 100
gram lyophilize powder. TPC of NEP fraction was 295.04±5.28 mg GAE/100g powder,
FC and TC of NEP fraction was 59.28±1.62 mg CE/100g and 52.66±0.49 mg CE/100g,
respectively. Phenolic acids, flavonols and flavanols of NEP were detected using accurate
mass and retention data (Table 4). Six compounds of flavonols and flavanols in NEP were
identified as ECG, EGCG, catechin, myricetrin, astragalin and myricetin. Moreover, five
phenolic acids were identified as p-coumaric acid, ferulic acid, protocatechuic acid,
caffeic acid and benzoic acid. NEP contained high levels of p-coumaric acid (23.56 ±4.4
mg/g extract), followed by caffeic acid (5.10 ±0.61 mg/g extract) and astragalin (3.50
±0.19 mg/g extract). The phenolic profiles of NEP in the present study were partly in
accordance with strawberry extractable phenolics in previous report by Aaby [222] due to
ripening and growing conditions of strawberry cultivar, low stability and degradation of
phenolics. Caffeic and coumaric acids have potential effects against lung and colon
cancer development at adhesion and migration steps of tumor progression [223]. Because
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NEP can be absorbed in the gut lumen and exert a biological effect upon their release by
microbiota [224], NEP play an essential role in delivering phenolics to the colon and
exhibiting biological activity. Thus, we further examined the anti-inflammation and anticancer efficacy of NEP.
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Figure. 8 TPC, flavonoids (FC) and tannin content (TC) in strawberry non-extractable
phenolic fractions (NEP) from 100 gram lyophilized powder. TPC was expressed as
means ± SD (n=3) of gallic acid equivalent (GAE). FC and TC were expressed as means
± SD (n=3) of catechin equivalent (CE).
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Figure. 9 Concentration-dependent inhibitory effect of NEP on LPS-induced NO
production of RAW 264.7 cells. RAW 264.7 cells were exposed to NEP (16, 32, 48 and
64 μg GAE/mL) with LPS (1.0 μg/mL) treatment. After 24 h of incubation, the amount of
NO in the culture supernatants was measured by Griess reaction assay. Values are
expressed as mean ± SD (n=6). Comparisons of means were made using one-way
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ANOVA followed by Student’s t- test. ** p< 0.01 indicated significant differences in
comparison to the LPS-treated group.
4.3.2 Inhibition of LPS-induced NO production by NEP

LPS-stimulated inflammatory models have been widely used to study the antiinflammatory activity of natural phenolics [225]. LPS can result in the release of proinflammatory cytokines and activate nitric oxide (NO) cascades [200]. NO is an
important fundamental component as a regulator and an effector molecule in many
physiological and pathophysiological process. Using non-toxic dose range established,
the effect of NEP on NO production induced by LPS (1µg/mL) in macrophages was
examined. The untreated group was taken as control in RAW 264.7 macrophages. NEP
treatment showed a notable reduction in the level of NO compared to control. As shown
in Figure 9, NEP had dose-dependent inhibition on NO production. NO production was
decreased to 68.65±5.33, 45.93±3.91, 26.95±5.68, and 21.55±1.81% at a dose range of
16-64 µgGAE/mL. The result showed that NEP exhibited the efficacy against LPSinduced damage in macrophages model.

4.3.3 Immunoblotting analysis

To investigate the molecular mechanism by which NEP inhibited inflammatory
response in macrophages, we further determined the effects of NEP on the protein levels
of iNOS, HO-1 and c-FOS by immunoblotting analysis. As shown in Figure 10, LPS
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increased protein expression of iNOS, HO-1, and c-FOS. The protein expression of iNOS
was decreased 11.8-fold by NEP treatment at 40 μg GAE/mL as compared to the LPStreated positive control group. HO-1 is an anti-oxidative enzyme that is associated with
anti-inflammatory effects [219]. Treatments with NEP at 40 μg GAE/mL significantly
increased the protein levels of HO-1 by 3.03-fold compared to the LPS-treated positive
control cells. AP-1 is a critical transcription factor involved in the pro-inflammatory
responses [226]. The effects of NEP on the levels of c-Fos, which is the key components
of AP-1 protein complex, were investigated. LPS treatment did decrease the level of cFos. These findings suggested that NEP might play a key role in preventing inflammation
as a promising strategy by whole strawberry dietary intake.

4.3.4 Anti-cancer effects of NEP in HCT-116 colon cancer cells

To investigate anti-cancer effect of NEP, nontoxic dose range of NEP in alpha
mouse liver 12 (AML-12) cells and normal colon cells (CCD-18) were firstly established.
The cell viability was evaluated by MTT assay. NEP did not show significantly cellular
toxicity at the concentrations from 0 to 60µg GAE/mL (Figure 11A). However, at the
same concentration range, NEP dose-dependently inhibited HCT-116 cell growth,
demonstrating a selective effect on cancer cells. As shown in Figure 4B, 60µg GAE/mL
NEP caused 10-fold lower cell viability (10.10±2.67%) than untreated HCT-116 (control,
100±3.57%).
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Figure. 10 Inhibitory effects of 40μg GAE/mL NEP treatment on LPS-induced protein
expression of iNOS, c-FOS and HO-1 in RAW 264.7 macrophages. β-actin was served as
an equal loading control.

Figure. 11 (A): cell viability of alpha mouse liver 12 (AML-12) and normal colon cell
(CCD-18) as normal cells treated with NEP. (B): concentration-dependent decrease in cell
viability of HCT-116 colon cancer cells. Cells were treated with or without NEP under
various concentrations for 24 h. Relative cell viability was assessed by MTT assay. The
results were represented as percentage (mean± SD) of living cells compared to control.
Comparisons of means were made using a one-way ANOVA followed by Student’s t-test
(n =6). *p<0.05, **p<0.01indicated the significant differences in comparison to the
control group.
4.3.5 NEP suppresses colony formation of HCT-116 cells
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A strong association of inflammation with colon cancer has been well recognized
[227]. Investing the anti-cancer potential of NEP is of great importance for better
understanding the bioactivity of strawberry. To examine long-term suppressive effects of
NEP treatment against the survival of HCT116 colon cancer cells, colony formation assay
was performed. HCT116 colon cancer cells were exposed to a serial concentration of
NEP for 14 days, using cells without NEP treatment as a control. As shown in Figure 12
A and B, NEP showed dose-dependent inhibitory effects on the HCT-116 colony
formation. The concentration of 1.25, 2.5, 5 and 10 μg GAE/mL reduced colony
formation to 88.28±4.16, 79.69±6.08, 66.41±4.73 and 45.70±4.00, respectively in
comparison to the control. Hence, NEP did cause long-term loss of survival of colon
cancer cells [216]. The results were consistent with the cell viability that we obtained
from the MTT assay. The results verified that NEP also poses significant antiproliferation effects of colon cancer, not merely the EP as mostly previous reports [228230].

4.3.6 NEP induced cell cycle arrest in G2/M phase in HCT-116colon cancer cells
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Figure. 12 Inhibitory effect of NEP on colony formation of HCT-116 human colon cancer
cells. Cells were seeded 400 cells/well in six-well plates. After 24 h of incubation, cells
were treated with serial concentrations of NEP. After 14 days of treatments, cells were
dyed and scanned (A). The number of colonies formed was counted as described in the
methods. Data represent means± SD, n=3 (B) all the treated groups showed significant
difference in comparison to the control (*, p<0.05).
Since many dietary phytochemicals have potential to inhibit carcinogenic process
by interfering with one or multiple cellular pathways and play an important role in cancer
chemoprevention [216]. To further understand the mechanism by which NEP inhibited
colon cancer cell proliferation, using the concentration range lower than 60 µg GAE/mL,
cell cycle distribution and cellular apoptosis were detected by flow cytometry. As shown
in Figure 13, the cell population in G2/M phase of HCT-116 cells treated with NEP at
20µg GAE/mL for 24 hours was significantly increased by 10% as compared to the
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control cells, while the percentage of G1 phase cell population was 6% decreased and S
phase was not changed in the present study (Figure 13A). It suggests DNA degradation
by leading to cell death (Figure 13B). These results revealed that NEP could interrupt the
cell cycle progression of colon cancer cells at the G2/M phase.

Figure. 13 NEP induced G2/M cell cycle arrest in colon cancer cell line (HCT116) after
24 hours exposure. (A): Percentage of cell population with and without 20 μg GAE/mL
NEP treatment. DMSO was used in the negative control. Data represent means ± SD
(n=3). *p <0.05 compared to the control. (B) and (C): PI-stained cells after NEP 20 μg
GAE/mL treatment and DMSO, respectively, was analyzed by flow-cytometry. The
percentage of cells in G0/G1, S and G2/M phase was calculated using Multicycle
software.
4.3.7 NEP induced cellular apoptosis in HCT-116 cells

Next, we sought to determine the effect of NEP on cellular apoptosis in HCT116
cells. Early and late apoptotic cells were quantified by Annexin-V/PI double staining in
HCT-116 after 48 h treatment as we described previously [216]. Early apoptotic cells
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(FITC-positive), viable cells (FITC-negative and PI-negative), late apoptotic and necrotic
cells (PI-positive and FITC-positive) were monitored using flow cytometry. As shown in
Figure 14A-14F, NEP at the concentration range of 10-40 µg GAE/mL did significantly
induce cellular apoptosis in HCT-116 cells. Compared to the control (1.17%), NEP at 10,
20, 30, 40µg GAE/mL markedly increased late apoptotic cells by 1.74- (from 1.17% to
2.03%), 5.56- (from 1.17% to 6.50%), 10.06- (from 1.17% to 11.77%) and 48.23-fold
(from 1.17% to 56.43), respectively. These results showed that NEP induced extensive
cellular apoptosis of HCT116 cells, which would be an effective approach to control
colon cancer progression.

Figure. 14 Effect of NEP on HCT-116 cells apoptosis. (A-E), cells were treated with
DMSO, 10, 20, 30, 40 μg GAE/mL NEP for 24 hours and subjected to flow cytometric
analysis after PI and Annexin V staining. (F): percentage of cell population at different
stages. All the treated groups showed significant difference in comparison to the controls
(*, p<0.05; **, p<0.01).
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4.4 Discussions

Phenolic compounds of strawberry have been extensively studied due to their
diverse health benefits as preventing chronic inflammation and cancer [231]. These
biological effects are closely associated with their non-nutritional phenolic constitutes. In
nature, phenolic compounds generally occur in two forms: one form is soluble extractable
phenolics (EP), another form is insoluble bound phonics (NEP). Lots of literatures have
demonstrated a wide range of biological activities of EP from millet, strawberry and
mulberry [211, 231-234]. The bioactivities of NEP from strawberry and other fruits were
scared [235]. Since NEP bound tightly with protein and fiber through hydrogen bonding
and hydrophobic interactions [236], acid, alkali and enzymatic hydrolysis methods have
been used to release NEP [209]. Thus the biological effects have been underestimated. In
this study, we used alkaline hydrolysis to release NEP from cell wall matrix of strawberry
powder. We found that NEP of strawberry mainly contained ECG, EGCG, catechin,
myricetrin, astragalin, myricetin, p-coumaric acid, ferulic acid, protocatechuic acid,
caffeic acid and benzoic acid. The phenolics constitutes were distinctly different from EP,
which contained plentiful anthocyanins (Table 4). The result was consistent with reports
described constituents of strawberry [237].

It has been extensively elucidated that various soluble extractable phenolics (EP)
inhibited to the growth of cancer cells by inducing cell cycle arrest and apoptosis, such as
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EP from blackcurrant [238], blueberry and raspberry [239], purple and red corn [229]. It
is well known that strawberry EP contribute greatly to the suppression of inflammation
and colon cancer by strawberry [233], while the effects of NEP were unclear. NEP can be
released by gut microbiota and subsequently well absorbed in vivo [240]. This prompted
us to explore whether NEP exhibits the similar anti-inflammation and anti-cancer effect
as EP.

NEP was extracted from strawberry by alkaline hydrolysis in this study. Our result
indicated that NEP at up to 60 µg GAE/mL showed significant inhibitory effect on HCT116 cells (Figure 11). Colony formation capability of colon cancer cells was also
markedly suppressed by NEP at 10 µg GAE/mL (Figure 12). Induction of cell cycle arrest
and cellular apoptosis in cancer cell is one of the effective strategies to control cancer
progression. Mechanistic investigation suggested that strawberry NEP was effective in
inducing colon cancer cellular apoptosis (Figure 14) and cell cycle arrest in G2/M phase
(Figure 13) and thus suppressed cell proliferation of HCT116 cells (Figure 13). Our
results at least partially enlarged the potent inhibitory activity of NEP on colon cancer.
Further studies are planned to carry out on more cancer cells.
Apoptosis is recognized to be activate mainly through the extrinsic death receptor
pathway and the intrinsic mitochondrial pathway [241]. The intrinsic mitochondrial
pathway is regulated by various intracellular signals, including the mitochondrial
response. The release of mitochondrial proteins, such as cytochrome C, can activate the
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caspase cascade that triggers cellular apoptosis [242]. Mitochondria have an key role in
pro-inflammatory signaling; in turn, pro-inflammatory mediators may also alter
mitochondrial function [243], Low grade and chronic inflammatory conditions can
increase the risk of malignancy from epidemiological studies and molecular studies.
Chronic inflammation exhibits tumor-promoting effects by various mechanisms,
including enhancing proliferation of malignant cells and promoting tumor angiogenesis
[219]. NO production not only is associated with the cell apoptosis, but also is an
important signaling molecule involved in regulating inflammatory response [244]. The
inflammatory response is characterized by coordinating activation of both pro- and antiinflammatory mediators [245]. LPS is the leading stimulus that initiates the macrophages
host response to release pro-inflammatory cytokines [246] and in turn activate a second
level of inflammatory cascades including cytokines, lipid mediators and adhesion
molecules such as NO [200]. Accumulating evidence suggests that phytochemistry plays
a crucial role in suppressing inflammatory response [155]. In present study, NEP
treatment can produce a significant suppression on NO production (Figure 9) and iNOS
expression in RAW264.7 macrophage cells. The results is in line with the reports
previously, in which the expression of inflammation marker iNOS was improved by
strawberry EP [200]. It demonstrated that the strong association between NO production
and iNOS expression.

Recently, several phytochemistry studies have demonstrated that HO-1 plays a
regulatory role in the inflammatory response by inhibiting production of proinflammatory cytokines [200, 219]. HO-1 has been implicated in the maintenance of
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cellular homeostasis and inhibition of the inflammatory response [246]. Herein, we
observed that NEP induced the increase HO-1 in the RAW 246.7 cells, which also
contributed to the anti-inflammatory effect.

In conclusion, our findings suggested that NEP exerted powerful preventive
ability against LPS-induced inflammation in macrophages, and inhibited the growth and
proliferation of colon cancer cells via inducing G2/M phase cell cycle arrest and
apoptosis. This information will provide important guidance for the chemoprevention
strategies of using strawberry as nutrient fruit through dietary administration.
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CHAPTER 5

DIETARY INTAKE OF WHOLE STRAWBERRY INHIBITED COLONIC
INFLAMMATION IN DEXTRAN SULFATE DODIUM-TREATED MICE VIA
RESTORING IMMUNE HOMEOSTASIS AND ALLEVIATING GUT
MICROBIOTA DYSBIOSIS

5.1 Introduction

Inflammatory bowel disease (IBD) has posed serious threats to the human health
[5], which lead to chronic malabsorption of nutrients, abnormal pain and rectal bleeding.
Both genetic predisposition and environmental factors contribute to the onset of IBD [5,
6]. Pathological immune response against exotic antigen and bacterial drives the
progression of IBD [247]. Multiple studies suggested that dysbiosis in colon plays an
important role in the development of colitis, and gut microbiota composition are different
between patients with IBD and healthy individuals [8]. The incidence of colonic
inflammation has also been associated with dietary patterns through the modification of
gut microbiota [248]. The diet with high fat, high sugar, high protein and low fiber has
been proposed to increase the risk of IBD. In contrast, dietary consumption of fruits and
vegetables has been associated with lowered risk of IBD [10].

Accumulating evidence suggests that colonic inflammation may be prevented by
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increased consumption of certain fruits and vegetables such as berries [10, 249]. Berries
(e.g. chokeberry, red raspberry, strawberry, cowberry) and their extracts have been shown
to have anti-inflammatory and anticancer effects in intestine in various animal models
such as AOM-induced rat colon cancer model, Apc 1638+/- mouse and Muc2-/- mouse
model, and DSS-induced colitis models [12-14]. Strawberry is one of the most popular
berry fruits, which is abundant in polyphenols that have been associated with antioxidation, anti-inflammation and anti-cancer bioactivities. Strawberry juice exhibited
anti-inflammatory effects in LPS-treated macrophage by decreasing the production of
pro-inflammatory cytokines [23], and inhibited the cell proliferation of human colon
cancer cell lines [17]. A human study showed that consumption of strawberry could
increase the serum antioxidant capacity [24]. The consumption of strawberry beverage
was associated with the amelioration of postprandial inflammatory response [25]. These
evidences suggested the promising bioactivity of berry fruits against the colonic
inflammation. Whole strawberry contains vitamins, flavonoids, phenolic acids,
anthocyanins, polysaccharides and fiber [17], which may exhibit stronger antiinflammatory effects when compared to the extracts. However, there is no detailed
mechanistic information available on the potential protective effects of whole strawberry
against IBD. Therefore, in this study, for the first time we determined anti-inflammatory
effect of whole strawberry in DSS-induced colitis in mice and elucidated the potential
mechanisms involved.
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5.2 Materials and methods

5.2.1 Animals, diet and experiment design

Male CD-1 mice were purchased from Charles River Laboratories (Wilmington,
MA, USA). All animal use was in compliance with regulations of Institutional Animal
Care and Use Committee of University of Massachusetts Amherst. The mice were
randomly divided into six groups (n=10) after one-week acclimation. Three groups were
treated with 1.5% (w/v) DSS in drinking water for 4 cycles (4 days/cycle, with 7-day
recovery after each of the first three DSS cycles) to induce colitis. These three colitic
groups were treated with AIN93G diet containing 0%, 2.5% or 5% (w/w) free-dried
whole strawberry powder, respectively, throughout the entire experiment. The other three
noncolitic groups were treated with regular drinking water plus AIN93G diet containing
0%, 2.5% or 5% (w/w) WS, respectively, throughout the entire experiment.

5.2.2 LC-MS analyses of polyphenols in whole strawberry powder

Polyphenols in whole strawberry powder were extracted with 80% acetone with
0.1% acetic acid for three times. Each time, the extraction mixture was sonicated for 30
min at room temperature, and then the supernatant was collected by centrifuging at 3,500
g for 5 min. The pooled supernatant was dried under vacuum and then re-dissolved in
50% methanol aqueous before analysis by LC-MS. Identification and quantification of
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polyphenols in strawberry were conducted using by LC-MS. Chromatographic separation
of polyphenols was carried out on Kinetex XB-C18 column (100 mm ×4.6 mm, 2.6 μm,
Phenomenex, Torrance, CA, USA). The mobile phase consisted of 0.1% formic acid in
95% water mixed with 5% CAN (solvent A), and 0.1% formic acid in ACN (solvent B).
The elution program was as follows: 0-2 min, isocratic elution with 5% B; 2-37 min, 595% B; 37-40 min, 95-100% B; 40-46 min, 100-5% B; 46-52 min, isocratic elution with
5% B. The flow rate was 0.4 mL/min, and injection volume was 10 µL. Pelargonidin 3glucoside, pelargonidin 3-rutinoside, proanthocyanidins B1, catechin, myricetin,
kaempferol were used as external standards, and pinostilbene was used as an internal
standard. All chemicals were from Sigma Aldrich.

5.2.3 Disease activity index (DAI), histological and immunohistochemistry evaluation

DAI was evaluated by the scores of bodies weight loss (the weight before each
DSS treatment compared to that after the DSS treatment, scored as: 0, no change; 1, 1-5%
loss; 2, 5-10% loss; 3, 10-20% loss), stool consistency (0, normal; 1, soft but firm; 2, soft;
3, diarrhea), and fecal blood (0, none; 1-2, blood; 3, gross bleeding) [250]. Once the mice
were sacrificed, colons were harvested and processed for histological analysis as we
previously described [176, 251, 252]. The score system was as follows: epithelium: 0,
normal; 1, loss of goblet cells; 2, loss of goblet cells in large areas; 3, loss of crypts; 4,
loss of crypts in large areas. Infiltration: 0, none; 1, infiltrate around crypt basis; 2,
83

infiltrate reaching to mucosae; 3: extensive infiltration to mucosae; 4: infiltration of
submucosa [253]. Immunohistochemistry analysis of the colon was performed as we
previously described [251, 254, 255]. Processed tissue sections were treated with a
primary antibody against inducible nitric oxide synthase (iNOS) and visualized after the
treatment with a biotin-conjugated secondary antibody (Dako, Santa Clara, CA, USA).

5.2.4 Western blot and enzyme-linked immunosorbent analysis (ELISA)

Colonic mucosa was scrapped and lysed in RIPA buffer containing a protease
inhibitor cocktail, and phosphotase inhibitor. Contents of protein were determined by
BCA kit. Samples were subjected to SDS-PAGE, and proteins were transferred to
nitrocellulose membranes. Membranes were then processed and visualized by Odyssey
CLx system (LI-COR Biosciences, Lincoln, NE, USA).

Colonic mucosa was scrapped and homogenized in MSD Tris Lysis buffer
(Rockville, Maryland, USA) containing protease inhibitor cocktail and phosphotase
inhibitor. The protein content was quantified by BCA kit, and then cytokines were
quantified by V-PLEX ELISA kit (Meso Scale Discovery, Rockville, Maryland, USA)
following the manufacture’s procedure.

5.2.5 Quantification of immune cells in the colonic mucosa and GSH/GSSG in the liver

Distal colons were lysed with Hanks’s balanced salt solution (1mM DTT and 5
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mM EDTA) for 2 h at 4 ℃ after washing with cold PBS. Seventy μm sorters (BD
Biosciences, San Jose, CS, USA) were used to obtain single-cell suspensions, followed
by the staining with APC-conjugated CD11c antibody, FITC-conjugated CD45 antibody,
PE/Cy7-conjugated Ly-6G/Ly-6C(Gr-1) antibody, PerCP/Cy5.5-conjugated F4/80
antibody, and isotype control antibody (Biolegend, San Diego, CA, USA). BD
LSRFortessa cell analyzer (BD Biosciences, San Jose, CA, USA) was used to quantify
the stained cells, and data were analyzed by FlowJo software.

Livers were rinsed in cold PBS before homogenization with PBS (1 mM EDTA),
followed by centrifugation at 10,000 g for 15 min at 4 ℃. Supernatants were
deproteinated with MPA reagent (Cayman Chemical, Ann Arbor, MI, USA). GSH and
GSSG were quantified by a glutathione assay kit (Cayman Chemical, Ann Arbor, MI,
USA).

5.2.6 Quantification of SCFAs by gas chromatography

SCFAs were extracted from cecal digesta with 0.05% phosphoric acid, followed
by the vortex and centrifugation for 20 min at 14,000 rpm at 4 ℃. Supernatants were
analyzed by gas chromatography with a flame ionization detector (Shimadzu GC-QP2010
SE, Tokyo, Japan). Identification of SCFAs was achieved by comparing with the
chemical standards (acetic acid, propionate acid, butyric acid, isovaleric acid, and valeric
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acid (Sigma-Aldrich, St. Louis, MO, USA)), and 2-ethylbutyric acid was used as the
internal reference.

5.2.7 Microbial analysis

Fecal pellets were store at -80 ℃ once being collected from mouse colon until
analysis. Bacterial DNA was extracted from feces using PowerFecal DNA isolation kit
(MoBio Laboratories, Inc., Carlsbad, CA, USA) following the manufacturer’s
instructions. The concentration of DNA was measured by NanoDrop Spectrophotometer
(ThermoScientific, Waltham, MA, USA). The primer sequences used to amplify V3-V4
regions of 16S rRNA gene was:16S Amplicon PCR Forward Primer =
5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG
and 16S Amplicon PCR Reverse Primer =
5’GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAA
TCC. The second PCR was conducted to attach dual indices and Illumina sequencing
adapters using Nextera XT Index Kit (Illumina, San Diego, CA, USA). PCR products
were quantified using Qubit dsDNA BR Assay kit (Life Technology, Carlsbad, CA,
USA), and the size of PCR products was verified by DNA analysis ScreenTape Assay on
Tape Station 2200 (Agilent Technologies, Santa Clara, CA, USA). PCR final products
were pooled in equimolar concentration and diluted to 4nM and denatured by NaOH.
After combining the amplicon library and PhiX control, the samples were loaded onto the
86

600-cycle MiSeq Reagent kit v3 cartridge and sequenced on an Illumina MiSeq platform
(Illumina Inc, San Diego, CA, USA).

Figure. 15 Dietary WS ameliorated symptoms of DSS-induced colitis in mice. (A) Body
weight change of mice, and disease activity index (DAI) (n=10 per group); (B) Colon
length and representative images of the mouse colon (n=8-10 per group); (C) Spleen
weights (n=8-10 per group); (D) Representative images of H&E staining of the colon
tissues (magnification: 300×) (n=6 per group); (E) Histological scores of colonic
abnormality (n=6 per group); (F) The ratio of GSH/GSSG in the liver (n=8-10 per group);
(G) Quantification of infiltrated immune cells in the distal colonic mucosa (n=6-8 per
group). Data present mean ± SD, and * indicates p<0.05, ** indicates p<0.01.
5.2.8 Data Analysis

Microbial data were analyzed by Quantitative insights into microbial ecology
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(QIIME) software pipeline v1.9.1. Comparison of two or more groups was analyzed by
either one-way parametric ANOVA followed by Tukey’s post hoc test or one-way
nonparametric ANOVA (Kruskal- Wallis test) followed by Dunn’s post hoc test.
Table 5. Phenolic Compounds Identified by LC-MS in Whole Strawberry Powder (freezedried). Data represented mean ± standard deviation (N = 3).
retention time
µg/g dry
compound
(min)
MS(m/z)
powder
pelargonidin 3-glucoside

9.22

433[M+H]＋

1398.02 ± 38.13

pelargonidin 3-rutinoside

9.56

580[M+H]＋

568.49 ± 32.45

proanthocyanidins B2

5.92

579[M+H]＋

97.28 ± 11.48

8.29

291[M+H]＋

254.27 ± 18.30

21.028

287[M+H]＋

17.47 ± 0.70

catechin
kaempferol
5.3 Results and discussion

5.3.1 Dietary whole strawberry inhibited colitic symptoms

The doses of WS used in the experiment were 2.5% and 5% (w/w) in the mouse
diet, which were equivalent to about 167 g (1.1 cup) and 334 g (2.2 cup) of fresh
strawberry per day per person (60 kg), respectively. These doses are within the achievable
range for humans. As shown in Figure 15A, during the experimental period, the body
weight of the control mice kept increasing (at a decreasing rate) and reached plateau at
the fourth DSS cycle. In contrast, DSS group (positive control) showed decreased body
weight during the third DSS cycle and continued body weight loss during the third
recovery period and the last DSS cycle. Dietary WS treatments slowed down the body
weight loss of the DSS-treated mice, especially those fed with 5% WS. The DAI of the
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DSS group was much higher than that of the control group, and WS at both 2.5% and
5.0% effectively decreased DAI (Fig. 15A). The shortening of the colon and increase of
spleen weight are indicators of severity of colitis. Our results showed WS reversed the
shortening of the colon and increase in spleen weight in colitic mice (Fig. 15B and C).
These results demonstrated that dietary WS effectively inhibited the severity of colitis in
DSS-treated mice. Strawberry is a rich source of bioactive components such as various
polyphenols. Using LC-MS, we quantified the abundance of pelargonidin 3-glucoside,
pelargonidin 3-rutinoside, proanthocyanidins B1, catechin, myricetin, and kaempferol in
the whole strawberry powder. The results were shown in the Table 5. All of these
components are potential contributors of the observed protective effects against colonic
inflammation in mice. It is important to note that there might be synergistic interactions
among different strawberry components, which might produce enhanced antiinflammatory effects. The exact mechanism of actions of each component and their
interactions are important focuses of future investigations.

5.3.2 Dietary whole strawberry ameliorated colonic injuries, reduced infiltration of
immune cells, and improved cellular anti-oxidative status.

Hematoxylin and Eosin (H&E) staining indicated that DSS treatment caused
severe colonic injuries, evidenced by the epithelium distortion, large areas of depletion of
goblet cells, damage of crypts and the infiltration of inflammatory cells, resulting in
89

much higher histopathological scores compared to the control group (Fig. 15D and E). In
contrast, WS treatments (2.5% and 5%) significantly reduced the abnormal
histopathological changes in the colon of the DSS-treated mice. The preserved colon
architecture suggested the protective effect of dietary WS (2.5% and 5%) against DSSinduced colonic injuries.

In response to DSS treatment, infiltration of immune cells increased in the mouse
colonic mucosa, which is similar to the situation of IBD patients [256]. Increased
infiltration of neutrophils was reported in DSS treated mice, along with the high oxidative
stress via production of ROS in the colon [257]. Our flow cytometry results indicated that
DSS treatment significantly elevated the infiltration of total immune cells, macrophage,
neutrophils and dendritic cells by 2.7-folds, 8.1-folds, 6.4-folds and 10.9-folds,
respectively, in the mucosa of the distal colons when compared to the control group (Fig.
15G). Dietary WS decreased the infiltration of these immune cells in the colon,
especially, dietary WS almost reversed the infiltration of macrophage, neutrophils and
dendritic cells. Similar to our results, polyphenol-rich apple extracts and red raspberries
were shown to reduce the immune cell infiltration in a rat model of colitis [258].

Innate immunity is activated when special cells recognize pathogens, and this
process triggers the production of ROS and cytokines that amplifies the host response
[259]. Increased oxidative stress has been associated with extensive infiltration of
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immune cells in DSS-induced colitis [260]. Antioxidants have been found effective in
attenuating colitis. Glutathione is the most important intracellular ROS scavenger, and its
depletion can be observed under inflammatory conditions [261]. We determined the ratio
of GSH/GSSG in the liver, and the data showed that GSH/GSSG was markedly reduced
in DSS-treated mice than the control mice, indicating the depletion of GSH and higher
level of ROS in the DSS group than that in the control (Fig. 15F). Dietary WS (2.5% and
5%) increased the GSH/GSSG ratio to the levels similar to that of the control mice, thus
suggesting the protective effects of WS against ROS in colitic mice.5.3.3 Dietary whole
strawberry decreased the production of proinflammatory cytokines
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Figure. 16 (A) Quantification of TNF-α, IL-1β, IFN-γ, IL-17, and IL-10 in the colonic
mucosa (n=6-8 per group); (B) Western blot analysis of key signaling proteins in the
colonic mucosa (Each lane contained protein of the colonic mucosa collected from the
colon of 2-3 individual animals that were pooled for immunoblot analysis. A total number
of 6-8 mice from each group were analyzed. Statistical significance in comparison with the
control (*p < 0.05, ** p < 0.01, n = 3)); (C) Representative immunohistochemistry images
of iNOS in the colonic tissues (magnification: 600×). Data present mean ± SD, and *
represents p<0.05, ** represents p<0.01.
Improper upregulation of proinflammatory cytokines is a marker of inflammation.
IL-10 is considered an anti-inflammatory cytokine, the expression of IL-10 in colitic
mice was higher than that in healthy mice (Fig. 16A), this may due to the self-defeating
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response, indicating more severe colitis in DSS-treated mice. Also, as shown in Fig. 16A,
DSS-treated mice showed drastically enhanced production of proinflammatory cytokines
in the colonic mucosa than the control, such as TNF-α, IL-1β, IFN-γ and IL-17. Dietary
WS effectively decreased the production of all five cytokines mentioned above in the
DSS-treated mice. Considering the data on immune cells and cytokines, the trend of
cytokine production in different groups was similar to that of the infiltration of the
immune cells (Fig. 15G and Fig. 16A), which was consistent with the notion that
infiltrated immune cells are the major producers of the various cytokines. These data
suggest that anti-inflammatory effect of WS were at least partially due to maintenance of
immune system homeostasis by reducing immune cell influx and overproduction of
proinflammatory cytokines in the colon.

5.3.3 Dietary whole strawberry modulated inflammation-related signaling proteins

To investigate the mechanism by which dietary WS inhibits the production of
inflammation mediators, the expression of COX-2 and iNOS were determined. We found
that levels of COX-2 and iNOS were elevated in colitic mice, whereas WS successfully
decreased their expressions (Fig. 16B and C). The NF-κB signaling pathway strongly
influences the pathogenesis of colitis, and dictates the expression of proinflammatory
proteins, such as COX-2 and iNOS, which markedly increased in the DSS-treated mice
[262]. The results showed that NF-κB pathway was activated in the colon of the colitic
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mice, evidenced by the elevated expression of p50, a vital subunit of NF-κB (Fig. 16B).
Dietary WS effectively suppressed the activation of NF-κB signaling. Similar to these
findings, polyphenol-rich fruits or extracts were found to suppress NF-κB signaling
pathway in DSS-treated rodent models [11, 14]. AP-1 is another critical pathway that
involved in the proinflammatory response. The DSS-induced colitis was associated with
increased expression levels of c-JUN, the key component in AP-1 pathway [263]. The
results showed the colonic level of c-JUN was increased by 5.6-fold in the colitic mice
than the control. Whereas, dietary WS (2.5% and 5%) treatments decreased the
expression of c-JUN by 73% and 91%, respectively in colitic mice.

The p53, an important tumor suppressor, can be activated and its expression level
has been found increased in colitis [264], the elevated p53 expression in colitic mice is
likely to be adaptive tissue response to facilitate the damaged cells. We found that the
expression of p53 was increased in the colitic mice, but it was decreased by dietary WS
treatments, suggesting the less severe colitis with dietary WS treatment. The activity of
cleaved caspase-3 (C-C 3) was found increased in both colon cancer cells treated with
LPS and the colon of the DSS-treated mice [265, 266], which may be related with tissue
injuries caused by the colonic inflammation. Consistent with these findings, Figure 16B
showed that DSS treatment increased expression levels of cleaved caspase 3 by 4.8-folds
compared to the control. Dietary WS (2.5% and 5%) suppressed the expression of
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cleaved caspase 3 by 76% and 98% compared to the DSS group, indicating that WS
protected the colonic tissues against DSS-induced tissue injuries.

5.3.4 Dietary whole strawberry alleviated gut microbiota dysbiosis

Accumulating evidence suggested that gut microbiota play a vital role in colonic
inflammation, and the change from “disease-free” to “disease” microbiota composition is
an important characteristic of IBD [267]. In the disease-free (noncolitic) mice, i.e. the
control and WS (2.5% or 5%) groups, 16S rRNA sequencing showed that 5% WS
treatment significantly increased α diversity of the microbiota, which was assessed by PD
whole tree (Fig. 17A), and modulated β diversity of the microbiota, which was assessed
by principal coordinate analysis of the weighted UniFrac Index(P<0.05, Fig. 17B),
although 2.5% WS did not cause significant change of α or β diversity of the gut
microbiota (Fig. 17A and 3B).
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Figure. 17 The effects of WS on gut microbiota. (A) Effect of WS on α diversity of fecal
bacteria in healthy mice, assessed by PD whole tree analysis; (B) Effect of WS on β
diversity of fecal bacteria in healthy mice, assessed by principal coordinates analysis; (C)
Effect of WS on α diversity of fecal bacteria in diseased mice, assessed by PD whole tree
analysis; (D) Effect of WS on β diversity of fecal bacteria in diseased mice, assessed by
principal coordinates analysis;(E) Relative abundance of bacteria taxa, different letters
mean statistically differences (p<0.05). *p<0.05. Data are presented as mean ± SEM or
median with 95% confidence interval (n=5).
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Figure. 18 LEfSe analysis of microbiota. (A) Taxonomic cladogram obtained from LEfSe
analysis of 16s sequences; (B) Only taxa meeting an LDA score threshold > 2 are shown.
The α diversity was significantly decreased in colitic mice compared with
noncolitic mice (Fig. 17C). 2.5% WS treatment did not significantly change α or β
diversity in colitic mice. However, 5% WS treatment profoundly increased α diversity of
colitic mice, which was assessed by PD whole tree (Fig. 17C). The β diversity was
profoundly changed in 5% WS-treated colitic mice (Fig. 17D), as observed in the
principal coordinates analysis of the weighted UniFrac Index. The three first principal
coordinates explained 82.73% of the variation observed between all the groups. The
change of gut microbiota between different groups was also evidenced by LEfSe analysis
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(Figure 18), and Fig. 4B showed the most differentially abundant taxons of different
groups. At the genus level, colitic mice showed 4.3-fold, 82.1-fold, 2.5-fold, and 2.8-fold
higher abundance of Akkermansia, Dorea, Bilophila and Bacteroides and 224.1-fold and
58.1-fold lower abundance of Bifidobacterium and Lactobacillus than the noncolitic
control mice, respectively (Fig. 17E). The LEfSe analysis also validated aforementioned
results (Fig. 18A and 4B). Linear discriminant analysis (LDA) showed the higher
abundance of Akkermansia, Dorea, Bilphila and Bacteroides in colitic mice than those in
non-colitic mice (Fig. 18B).In consistent with our results, Akkermansia shows positive
correlation with IBD patients [268], which may due to the Akkermansia’s mucindegrading ability and its highly immunostimulatory lipopolysaccharide activity,38 which
results in high production of pro-inflammatory cytokines. Mucin is the major component
of colonic mucosa, and the increased amount of Akkermansia may contribute to the
mucosa damage. And dietary WS decreased both pro-inflammatory cytokines and the
abundance of Akkermansia (Fig. 16A,17E and 18). The enrichment of Bilophila, as an
opportunistic pathogen, is reported in colitis mice [269], which is similar to our results.
Commensal Bacteroides was reported to induce colitis in mice, which is supportive to
their potential role in pro-inflammation in the colitic mice that hosted higher abundance
of Bacteroides than the noncolitic mice in this study [270]. Bifidobacterium and
Lactobacillus have shown protective effects against colonic inflammation. Low
abundance of these two bacteria in colitic mice might contribute to the development of
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colitis. Intriguingly, dietary WS (2.5%) treatment at least partially or even completely
reversed the alterations of gut microbiota in colitic mice by decreasing the abundance of
Akkermansia, Dorea, Bilophila and Bacteroides, and increasing the abundance of
Bifidobacterium and Lactobacillus. These results demonstrated dietary WS alleviated
microbiota dysbiosis in DSS-induced colitis.

5.3.5 Dietary whole strawberry restored the production of SCFAs in the cecum

It has been shown that IBD was usually associated with change of gut microbiota,
and concurrent decrease of SCFAs [260]. SCFAs have been found to have antiinflammatory effects, and they were mainly produced by Bacteroidetes and Firmicutes
phyla [271]. The data showed that the cecal levels of acetic acid, propionate acid, butyric
acid, and valeric acid in the colitic mice 45.6%, 19.4%, 60.8% and 44.5% lower than that
in the noncolitic control mice, respectively (Fig. 19A). Concomitantly, the abundance of
Firmicutes was much lower in the colitic mice than the noncolitic control, which might
contribute to the low levels of SCFAs.42 Dietary WS (2.5%) did not change the cecal
levels of SCFAs in the noncolitic mice, but significantly increased the production of
SCFAs in the colitic mice to the same levels found in the noncolitic control mice. Since
WS did not increase the levels of SCFAs in noncolitic mice, it is likely that dietary WS
increased SCFAs production in the colitic mice due to its effects in altering the
composition of gut microbiota, such as increasing the abundance of Firmicutes.
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Figure. 19 (A) Quantification of SCFAs in the cecum. (B) Heatmap of the correlation
between bacteria and cytokines or SCFAs. Data are presented as mean ± SD (n=5), and *
represents p<0.05, ** represents p<0.01.
According to these results, colitic mice had improper upregulation of cytokines in
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the colonic tissue, reduced production of SCFAs in the cecum, and increased abundance
of pathogens and decreased abundance of beneficial bacterial species in the feces, when
compared to the noncolitic control mice. Intriguingly, dietary WS effectively alleviated
and/or reversed the aforementioned abnormality in the colitic mice. Since gut microbiota
are responsible for the production of SCFAs in the colon, and can modulate the secretion
of pro-inflammatory cytokines, especially when there is dysbiosis in the colon, to
understand the role of gut microbiota in mediating the protective effects of dietary WS
against colitis, the correlation between composition of gut microbiota and production of
cytokines or SCFAs among the different experimental groups of mice was analyzed (Fig.
19B). The results showed that Akkermansia and Dorea presented a negative correlation
with the production of SCFAs, especially for the butyrate that is an important antiinflammatory component in the colon. Moreover, Akkermansia and Dorea also showed a
strong positive correlation with TNF-α, a proinflammatory cytokine. Considering the
relatively higher abundance of Akkermansia and Dorea in colitic mice than that in the
non-colitic control mice (Fig 17E), Akkermansia and Dorea may exert proinflammatory
effects in DSS-induced colitis. Consistent with our findings, the increase of Akkermansia
and Dorea was previously reported in the DSS-induced colitis [272, 273]. The abundance
of Bifidobacterium and Lactobacillus was negatively correlated with the production of
TNF-α, and positively correlated with the production of butyrate, indicating a potential
protective effect of these bacteria against colonic inflammation [274].
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For the first time, these results demonstrated the protective effect of dietary WS
against the development of colonic inflammation in the DSS-treated mice. This protective
effect was closely associated with restoration of immune homeostasis by dietary WS,
which was evidenced by that dietary WS reduced immune cell infiltration and lowered
levels of proinflammatory cytokines in the colonic mucosa of colitic mice. The antiinflammatory effects of dietary WS were also closely related with its ability to alleviate
the dysbiosis of gut microbiota in the colitic mice, which was evidenced by the increased
abundance of beneficial bacteria, the decreased abundance of harmful bacteria, and the
increased production of SCFAs caused by dietary WS in the colon of the colitic mice.
Overall, our findings provided a solid scientific basis for utilization of strawberry for the
prevention of colonic inflammation.
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CHAPTER 6

CONCLUDING REMARKS

Intake of whole foods, such as fruits and vegetables, profoundly modulates the
composition and function of gut microbiota. These alterations of gut microbiota may (i)
produce a better health status in disease-free population to lower the risks of various
diseases, and (ii) alleviate the disease severity in patients with microbiota-associated
diseases such as obesity and colonic inflammation. MACs and polyphenols are two major
types of components responsible for the modulating effects of fruits and vegetables on
gut microbiota. They have a reciprocal interaction with gut microbiota, in which MACs
and polyphenols alter the structure of microbiota and microbiota transforms MACs and
polyphenols to bioactive metabolites, such as SCFAs and phenolic acids, respectively.
These microbiota-derived metabolites could promote host health by targeting both host
tissues and gut microbiota. Furthermore, coexistence of whole food components, their
metabolites and microbiota in the large intestine provides opportunities for them to
interact with each other and produce certain biological functions that are otherwise
impossible. The relationship among whole foods, gut microbiota, and the host is
complex, which makes it challenging to study. Nevertheless, a highly interdisciplinary
and dynamic approach giving special considerations of the physiological relevance of the
experimental conditions is needed to elucidate the role of whole foods in modulating gut
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microbiota and associated diseases.

This study provided an understanding of EP and NEP from cranberry and
strawberry in terms of their chemical properties and biological functions. Chemical
profile of cranberry and strawberry NEP was firstly determined, which showed that NEP
possessed higher contents of phenolic acids than EP. EP fraction in fruits have been
extensively studied, such as their anti-oxidant, anti-inflammatory, anti-cancer, and
antibacterial effects. However, reports about NEP have been scarce. NEP could bind to
fiber and they may reach colon intact [15], so that the biological effects of NEP have
been considered important for colon health. Our results indicated that both EP and NEP
from cranberry had various biological effects. Importantly, NEP showed the promising
anti-inflammatory and anti-cancer capacities. The high bioavailability of NEP in the
colon facilitate the realization of these activities in the colonic tissues. Moreover, the
potential interaction between gut microbiota and NEP could also play an important role in
colon health. NEP could be biotransformed by gut microbiota to produce bioactive
metabolites that may contribute to the promotion of colon health as well [197].
Therefore, it is important to investigate the interaction of gut microbiota and NEP in the
colon in terms of production of bioactive metabolites. Meanwhile, composition and
functions of gut microbiota can be altered by the presence of polyphenols in the colon,
which in turn could affect colon health [198]. Unfortunately, the mode of interplay
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between NEP and gut microbiota in the colon is largely unknown, and much more efforts
are needed to explore this promising research area. The knowledge obtained from our
study is helpful for a better understanding of polyphenols in berries, especially the
potential biological effects of NEP in the colon. Overall, this study provided the first line
of evidence to support the notion that NEP could be a promising beneficial agent for
colon health. Certainly, further investigation is warranted to elucidate the detailed model
of actions of NEP in the colon, especially in relationship with gut microbiota.

Furthermore, this study demonstrated the protective effect of dietary WS against
the development of colonic inflammation in the DSS-treated mice. This protective effect
was closely associated with restoration of immune homeostasis by dietary WS, which
was evidenced by that dietary WS reduced immune cell infiltration and lowered levels of
proinflammatory cytokines in the colonic mucosa of colitic mice. The anti-inflammatory
effects of dietary WS were also closely related with its ability to alleviate the dysbiosis of
gut microbiota in the colitic mice, which was evidenced by the increased abundance of
beneficial bacteria, the decreased abundance of harmful bacteria, and the increased
production of SCFAs caused by dietary WS in the colon of the colitic mice. Overall, our
findings provided a solid scientific basis for utilization of strawberry for the prevention of
colonic inflammation.
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